<?xml version="1.0" encoding="UTF-8"?>
<svg height="741.338" width="548.662" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="95.358" x="56.693,60.106,61.381,71.716,75.279,78.464,82.439,84.359,89.845,91.12,93.203,97.058,98.54,101.724,105.699,107.659,112.113,113.388,115.426,120.912,124.026,128.03,129.512,132.925,138.71,142.123,145.907,148.058,150.75799999999998,152.786,157.382,159.826,161.101,163.161,167.757,171.169,172.651,174.133,177.318,180.731,182.804,186.104,188.049,191.832,193.78199999999998,195.816,197.298,198.78,202.634,206.418,210.272,214.056,215.538,217.02,218.502,221.80200000000002,223.822,227.676,229.158,232.942,236.126,239.24,241.392,242.874,246.059,249.471,252.065,253.34,255.399,258.584,261.178,263.771,267.184,272.969,276.824,278.306,281.419" svgx:width="0.48,0.17,0.55,0.5,0.45,0.53,0.55,0.77,0.17,0.55,0.54,0.21,0.45,0.53,0.55,0.63,0.17,0.55,0.77,0.44,0.56,0.21,0.48,0.81,0.48,0.53,0.3,0.36,0.55,0.64,0.34,0.17,0.55,0.64,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.21,0.53,0.45,0.44,0.3,0.21,0.45,0.48,0.36,0.17,0.55,0.45,0.36,0.36,0.48,0.81,0.54,0.21,0.44,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">9. Yao M, Xiao H, McClements DJ. Delivery of lipophilic bioactives: assembly,</text>
   <text y="104.315" x="71.716,75.571,77.053,79.646,82.831,85.425,88.018,91.431,97.216,101.071,102.553,105.667,106.94200000000001,109.02,112.204,115.988,120.038,121.946,124.019,127.432,130.617,133.21,135.803,139.216,145.002,148.856,150.338,153.638,155.621,159.404,161.35399999999998,163.388,164.87,166.352,170.206,171.688,175.738,177.731,181.514,184.699,188.482,192.265,196.12,199.305,201.378,203.53,205.012,208.126,209.607,213.02,215.614,216.889,218.945,223.099,226.883,230.666,234.566,236.52,240.082,243.495,246.87,248.822,252.085,255.868,259.651,263.701,265.659,268.922,272.036" svgx:width="0.54,0.21,0.36,0.45,0.36,0.36,0.48,0.81,0.54,0.21,0.44,0.17,0.55,0.45,0.53,0.54,0.55,0.29,0.48,0.45,0.36,0.36,0.48,0.81,0.54,0.21,0.44,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.53,0.45,0.53,0.53,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.36,0.17,0.55,0.58,0.53,0.53,0.52,0.55,0.5,0.48,0.45,0.55,0.46,0.53,0.53,0.54,0.55,0.46,0.44,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">disassembly, and reassembly of lipid nanoparticles. Annu Rev Food Sci</text>
   <text y="113.329" x="71.716,74.98,78.392,81.506,85.289,89.073,92.856,94.338,95.613,97.625,101.038,104.45,107.863,111.276,112.459,115.872,117.054,120.467" svgx:width="0.46,0.48,0.44,0.53,0.53,0.53,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Technol. 2014;5:53</text>
   <text y="113.329" x="123.931" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="113.329" x="127.445,130.858,134.271" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">81.</text>
   <text y="122.569" x="56.692,60.105,63.518,64.793,71.716,75.87,79.653,81.805,85.588,89.56299999999999,91.501,96.025,97.30000000000001,99.325,102.887,106.072,109.855,113.71,116.895,122.68,128.466,132.066,134.02,137.283,140.547,141.822,143.885,148.409,151.594,155.377,159.16,161.234,164.647,170.432,174.137,175.619,178.212,179.694,183.478,187.261,189.96099999999998,192.015,195.2,198.984,203.03400000000002,204.998,210.783,212.265,215.379,217.452,221.235,223.309,226.722,232.507,236.212,237.694,240.287,241.769,245.553,249.336,251.929,253.204,255.283,258.397,259.879,263.063,265.137,266.619,268.471,269.953,273.067,276.252,278.403,279.885,283.669,287.452" svgx:width="0.48,0.48,0.17,0.55,0.58,0.53,0.3,0.53,0.53,0.55,0.63,0.17,0.55,0.5,0.45,0.53,0.54,0.45,0.81,0.81,0.48,0.55,0.46,0.46,0.17,0.55,0.63,0.45,0.53,0.53,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.45,0.53,0.54,0.55,0.81,0.21,0.44,0.29,0.53,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.17,0.55,0.44,0.21,0.45,0.29,0.21,0.26,0.21,0.44,0.45,0.3,0.21,0.53,0.53,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">10. Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications</text>
   <text y="131.584" x="71.716,75.499,77.449,79.483,81.634,85.418,89.018,90.934,94.048,96.121,97.603,99.755,101.237,104.351,107.535,109.11,111.173,115.028,116.51,118.362,120.215,123.628,125.701,129.114,132.897,136.011,139.424,142.017,143.292,145.359,148.921,152.704,155.889,157.963,164.03799999999998,165.938,169.501,172.914,175.507,176.782,178.807,182.22,185.633,189.046,192.459,193.641,197.054,200.467,201.65,205.063,208.475" svgx:width="0.53,0.26,0.55,0.3,0.53,0.48,0.55,0.44,0.29,0.21,0.3,0.21,0.44,0.45,0.21,0.55,0.54,0.21,0.26,0.26,0.48,0.29,0.48,0.53,0.44,0.48,0.36,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">of the critical differences. Pharm Res. 2011;28:978</text>
   <text y="131.584" x="211.917" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="131.584" x="215.432,218.845,222.258" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">85.</text>
   <text y="140.824" x="56.691,60.104,63.517,64.792,71.715,77.201,80.315,84.319,85.801,89.214,94.999,98.412,102.195,104.347,107.047,109.074,113.67,116.114,117.38900000000001,119.449,122.634,124.209,126.252,129.814,131.089,133.112,136.375,138.527,140.6,144.305,147.419,149.57,153.275,155.349,158.761,162.811,164.803,168.215,174.001,177.706,179.188,181.781,183.263,187.046,190.83,192.903,196.758,199.943,202.536,205.949,209.99900000000002,211.97,215.825,219.237,220.719,222.201,225.386,228.799,230.872,234.17200000000003,236.121,238.714,241.828,244.421,246.573,249.986,255.771,258.365" svgx:width="0.48,0.48,0.17,0.55,0.77,0.44,0.56,0.21,0.48,0.81,0.48,0.53,0.3,0.36,0.55,0.64,0.34,0.17,0.55,0.45,0.21,0.55,0.5,0.17,0.55,0.46,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.54,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">11. McClements DJ, Li Y. Structured emulsion-based delivery systems:</text>
   <text y="149.838" x="71.715,74.829,78.612,82.395,84.547,86.62,90.404,91.886,93.368,94.85,98.633,102.68299999999999,104.596,106.748,110.532,114.13199999999999,116.105,119.96,121.442,125.296,128.709,131.303,133.454,134.936,138.72,142.695,144.621,147.806,151.589,155.639,157.604,159.677,163.09,164.572,167.985,171.169,173.763,177.363,179.317,183.1,185.04999999999998,187.141,188.623,190.105,193.959,197.742,201.597,205.38,206.862,208.344,209.826,213.126,215.089,216.942,220.725,224.509,228.559,230.51,233.623,237.407,243.192,247.047,250.83,254.613,258.026,261.81,263.961,266.555,267.83,269.854,274.007,277.862" svgx:width="0.44,0.53,0.53,0.3,0.29,0.53,0.21,0.21,0.21,0.53,0.54,0.55,0.3,0.53,0.48,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.29,0.48,0.21,0.48,0.45,0.36,0.48,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.26,0.53,0.53,0.54,0.55,0.44,0.53,0.81,0.54,0.53,0.53,0.48,0.53,0.3,0.36,0.17,0.55,0.58,0.54,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">controlling the digestion and release of lipophilic food components. Adv</text>
   <text y="158.852" x="71.715,75.719,79.503,80.985,82.467,86.25,87.732,91.782,93.712,95.194,98.977,101.129,104.542,106.615,108.565,110.606,113.869,116.982,118.464,119.739,121.774,125.187,128.6,132.012,135.425,136.608,140.021,143.434,146.846,148.029,151.442,154.855" svgx:width="0.56,0.53,0.21,0.21,0.53,0.21,0.54,0.55,0.21,0.53,0.3,0.48,0.29,0.26,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Colloid Interf Sci. 2010;159:213</text>
   <text y="158.852" x="158.285" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="158.852" x="161.857,165.27,168.683" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">28.</text>
   <text y="168.093" x="56.691,60.104,63.517,64.792,71.715,74.978,77.052,78.534,81.647,84.611,88.024,90.199,92.238,96.612,97.887,99.947,103.432,105.505,109.288,115.074,119.124,121.037,124.3,125.575,127.67,133.456,136.869,140.652,144.507,147.919,149.494,151.537,155.691,156.966,159.021,162.583,164.065,167.77,173.556,177.156,179.089,183.243,184.518,186.573,190.356,191.838,193.911,196.875,200.288,201.863,203.92,206.364,207.639,209.703,213.265,216.678,220.533,226.318,229.503,233.286,237.261,239.183,243.636,244.911,246.95,250.213,253.626,255.778,258.592,262.005,264.18,266.225,270.229" svgx:width="0.48,0.48,0.17,0.55,0.46,0.29,0.21,0.44,0.42,0.48,0.29,0.55,0.61,0.17,0.55,0.49,0.29,0.53,0.81,0.54,0.55,0.46,0.17,0.55,0.81,0.48,0.53,0.54,0.48,0.21,0.55,0.58,0.17,0.55,0.5,0.21,0.52,0.81,0.48,0.55,0.58,0.17,0.55,0.53,0.21,0.29,0.42,0.48,0.21,0.55,0.34,0.17,0.55,0.5,0.48,0.54,0.81,0.45,0.53,0.53,0.55,0.63,0.17,0.55,0.46,0.48,0.3,0.4,0.48,0.29,0.55,0.56,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">12. Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, Setzer C,</text>
   <text y="177.107" x="71.715,76.46,80.165,81.647,85.43,88.394,91.807,93.881,96.131,98.19,101.752,106.497,107.772,109.812,115.298,118.483,120.556,122.708,124.19,128.165,130.108,133.371,134.64600000000002,136.684,142.17,145.875,147.357,148.839,152.252,154.325,156.399,160.773,164.557,167.67,173.456,176.641,180.424,184.399,186.402,190.407,191.68200000000002,193.715,197.278,201.061,204.845,207.438,211.293,215.076,218.859,220.341,221.823,225.678,227.16,231.014,233.714,235.781,238.966,242.749,246.799,248.763,250.245,251.727,255.582,257.064,260.918,262.992,266.846,270.031,272.624,276.037" svgx:width="0.67,0.52,0.21,0.53,0.42,0.48,0.29,0.3,0.55,0.5,0.67,0.17,0.55,0.77,0.45,0.29,0.3,0.21,0.53,0.55,0.46,0.17,0.55,0.77,0.52,0.21,0.21,0.48,0.29,0.29,0.61,0.53,0.44,0.81,0.45,0.53,0.53,0.55,0.56,0.17,0.55,0.5,0.53,0.53,0.36,0.54,0.53,0.53,0.21,0.21,0.54,0.21,0.54,0.36,0.55,0.45,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Quinkert RO, Martin F, Müller-Goymann C. Phospholipids and lipid-based</text>
   <text y="186.065" x="71.715,73.568,77.351,79.424,85.21,88.915,90.397,93.581,95.733,97.215,100.998,104.782,107.482,109.528,111.01,114.985,116.898,120.682,122.755,125.94,127.515,129.597,133.452,135.525,139.23,143.28,145.244,149.099,152.511,153.993,155.475,158.66,162.073,164.146,167.26,168.535,170.585,174.148,177.931,181.116,183.189,189.26399999999998,191.108,194.67,198.083,200.676,201.951,204.034,207.447,210.859,214.272,217.685,218.868,222.281,225.693,226.876,230.289,233.702,237.115" svgx:width="0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.21,0.53,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">formulations in oral drug delivery. Pharm Res. 2010;27:1469</text>
   <text y="186.065" x="240.547" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="186.065" x="244.061,247.474,250.887" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">86.</text>
   <text y="195.306" x="56.691,60.104,63.516,64.791,71.714,76.167,79.352,81.426,82.908,86.691,88.266,90.309,94.313,98.096,101.88,106.995,110.85,114.035,116.108,119.408,121.376,124.938,126.21300000000001,128.235,131.798,133.871,137.056,139.65,142.834,146.618,150.401,153.776,155.787,159.35,162.535,164.017,167.917,169.847,173.409,174.684,176.707,180.269,183.454,186.048,189.232,192.417,195.83,198.424,203.539,206.724,208.797,212.172,214.18,217.743,220.928,224.903,226.879,232.365,235.928,237.203,239.238,242.8,245.985,248.579,252.362,255.775,259.188,263.238,265.202,269.356,270.631,272.629,274.111" svgx:width="0.48,0.48,0.17,0.55,0.63,0.45,0.29,0.21,0.53,0.21,0.55,0.56,0.53,0.53,0.72,0.54,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.29,0.45,0.36,0.45,0.53,0.53,0.45,0.55,0.5,0.45,0.21,0.52,0.55,0.5,0.17,0.55,0.5,0.45,0.36,0.45,0.45,0.48,0.36,0.72,0.45,0.29,0.45,0.55,0.5,0.45,0.53,0.55,0.77,0.5,0.17,0.55,0.5,0.45,0.36,0.53,0.48,0.48,0.54,0.55,0.58,0.17,0.55,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">13. Harini Chowdary V, Prasanna Raju Y, Basaveswara Rao MV, Rasheed A. In</text>
   <text y="204.32" x="71.714,74.899,76.381,78.533,80.606,84.58099999999999,86.511,89.624,93.408,96.592,98.666,101.851,104.964,107.116,110.529,112.602,114.084,116.898,120.083,122.235,123.717,127.5,131.475,133.452,136.045,138.197,141.902,145.756,147.238,150.651,153.351,155.391,159.175,161.125,163.158,165.752,169.164,170.646,172.59599999999998,174.666,180.452,181.934,185.047,187.121,190.904,194.317,200.102,203.807,205.289,207.883,209.365,211.217,212.699,216.112,220.162,222.117,225.972,229.755,232.349,235.762,239.545,241.697,244.881,248.856,250.804,253.397,256.511,259.104,261.256,264.669,270.454,273.048" svgx:width="0.45,0.21,0.3,0.29,0.53,0.55,0.44,0.53,0.45,0.29,0.45,0.44,0.3,0.48,0.29,0.21,0.4,0.45,0.3,0.21,0.53,0.53,0.55,0.36,0.3,0.52,0.54,0.21,0.48,0.36,0.55,0.53,0.26,0.55,0.36,0.48,0.21,0.26,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.21,0.48,0.54,0.55,0.54,0.53,0.36,0.48,0.53,0.3,0.45,0.53,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">vitro characterization studies of self microemulsified bosentan systems.</text>
   <text y="213.334" x="71.714,76.31,78.383,82.088,86.13799999999999,88.098,92.694,96.106,99.481,101.421,102.903,106.686,110.736,112.646,116.209,119.992,123.177,125.25,131.036,132.311,134.416,137.828,141.241,144.654,148.067,149.25,152.662,156.075,157.258,160.671,164.084" svgx:width="0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.45,0.55,0.21,0.53,0.54,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Drug Dev Ind Pharm. 2017;43:989</text>
   <text y="213.334" x="167.469" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="213.334" x="171.04,174.453,177.866" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">95.</text>
   <text y="222.575" x="56.691,60.104,63.516,64.791,71.714,75.719,79.502,83.285,85.879,88.03,91.215,94.999,97.15,98.632,102.416,103.898,107.752,111.165,113.86500000000001,115.877,119.44,123.002,124.277,126.365,129.55,132.735,136.518,139.632,142.817,145.41,147.562,150.975,153.15,155.165,159.169,164.655,165.93,167.977,173.464,176.648,178.722,181.835,185.248,186.73,188.212,192.18699999999998,194.169,196.613,197.888,199.952,203.956,207.739,209.221,213.005,215.598,218.192,221.975,225.758,229.358,231.302,235.898,239.902,241.177,243.264,248.009,250.083,253.866,257.279,259.454,261.462,266.057" svgx:width="0.48,0.48,0.17,0.55,0.56,0.53,0.53,0.36,0.3,0.45,0.53,0.3,0.21,0.53,0.21,0.54,0.48,0.36,0.55,0.5,0.5,0.17,0.55,0.45,0.45,0.53,0.44,0.45,0.36,0.3,0.48,0.29,0.55,0.56,0.77,0.17,0.55,0.77,0.45,0.29,0.44,0.48,0.21,0.21,0.53,0.55,0.34,0.17,0.55,0.56,0.53,0.21,0.53,0.36,0.36,0.53,0.53,0.48,0.55,0.64,0.56,0.17,0.55,0.67,0.29,0.53,0.48,0.29,0.55,0.64,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">14. Constantinides PP, Lancaster CM, Marcello J, Chiossone DC, Orner D.</text>
   <text y="231.589" x="71.714,74.978,78.761,82.544,85.729,89.512,92.626,96.039,100.089,102.044,103.526,107.31,109.461,112.874,115.468,117.619,119.101,122.885,126.069,127.644,129.653,132.838,136.693,139.286,143.07,145.143,148.997,151.149,152.631,156.414,160.38899999999998,162.364,166.148,168.09799999999998,170.131,173.316,177.291,179.259,182.821,187.196,191.996,193.942,197.797,201.209,205.064,207.216,208.698,212.552,216.152,218.093,219.945,222.018,225.802,231.87699999999998,233.74,238.855,242.04,244.192,247.605,249.678,251.751,253.233,257.208,259.194,262.977,264.459" svgx:width="0.46,0.53,0.53,0.45,0.53,0.44,0.48,0.54,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.45,0.53,0.55,0.5,0.61,0.64,0.55,0.54,0.48,0.54,0.3,0.21,0.54,0.48,0.55,0.26,0.29,0.53,0.81,0.55,0.72,0.45,0.3,0.48,0.29,0.29,0.21,0.53,0.55,0.53,0.21,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Enhanced intestinal absorption of an RGD peptide from water-in oil</text>
   <text y="240.603" x="71.714,77.5,78.982,82.095,84.169,87.952,91.365,97.15,100.855,102.337,104.931,106.413,110.196,113.979,116.679,118.712,122.495,124.44500000000001,126.478,130.333,131.815,133.667,135.52,138.933,141.006,144.419,148.202,150.452,152.5,155.614,159.397,165.182,169.037,172.82,175.414,176.896,179.047,180.529,184.313,188.28799999999998,190.257,193.442,197.225,201.275,203.239,207.094,210.279,212.352,214.504,215.986,219.099,220.581,224.18099999999998,226.143,228.736,230.218,233.033,236.446,237.721,239.749,242.299,244.341,248.345,252.128,255.912,258.063,260.238,262.312,265.874,269.287,270.769" svgx:width="0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.53,0.26,0.55,0.54,0.21,0.26,0.26,0.48,0.29,0.48,0.53,0.3,0.55,0.44,0.53,0.81,0.54,0.53,0.36,0.21,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.55,0.36,0.21,0.4,0.48,0.17,0.55,0.34,0.55,0.56,0.53,0.53,0.3,0.29,0.55,0.5,0.48,0.21,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">microemulsions of different composition and particle size. J Contr Rel.</text>
   <text y="249.56" x="71.714,75.127,78.54,81.953,85.366,86.548,89.961,93.374,94.557,97.97,101.382" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">1995;34:109</text>
   <text y="249.56" x="104.766" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="249.56" x="108.338,111.751,115.163" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">16.</text>
   <text y="258.801" x="56.69,60.103,63.516,64.791,71.714,75.059,78.63,79.934,82.712,86.687,88.268,91.556,92.831,94.448,98.076,101.08,104.652,108.224,111.228,113.40299999999999,115.027,118.995,120.27000000000001,121.943,126.139" svgx:width="0.48,0.48,0.17,0.55,0.5,0.53,0.21,0.42,0.53,0.55,0.49,0.17,0.55,0.53,0.45,0.53,0.53,0.45,0.29,0.55,0.58,0.17,0.55,0.61,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">15. Bolko K, Zvonar A, Ga</text>
   <text y="258.801" x="129.144" svgx:width="0.36" style="fill:rgb(19,20,19);font-family:PyfygrAdvTTb5929f4c;font-size:7.5px;stroke:none;">š</text>
   <text y="258.801" x="131.525,135.196,138.426,140.316,141.615,142.914,146.88899999999998,148.413,153.716,154.991,156.665,161.968,163.266,166.126,169.301,173.351,174.913,176.212,177.511,181.139,182.438,186.488,188.05,191.722,195.322,198.324,200.734,204.334,205.893,208.955,214.258,217.338,221.751,226.163,229.613,231.152,234.156,236.856,238.465,241.469,245.444,246.968,248.272,251.873,255.473,259.073,262.075,265.076,267.045,268.344,271.292" svgx:width="0.54,0.48,0.29,0.21,0.21,0.53,0.55,0.77,0.17,0.55,0.77,0.21,0.43,0.48,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.53,0.45,0.36,0.48,0.55,0.46,0.77,0.46,0.64,0.64,0.46,0.55,0.45,0.36,0.55,0.45,0.53,0.55,0.21,0.53,0.53,0.53,0.45,0.45,0.3,0.21,0.45,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">perlin M. Mixed lipid phase SMEDDS as an innovative</text>
   <text y="267.815" x="71.714,74.73,78.358,82.043,83.914,87.529,90.477,93.422,97.39699999999999,98.921,100.904,104.87899999999999,106.403,109.647,113.261,116.833,119.837,123.409,126.357,129.957,131.516,133.387,136.631,139.013,142.029,145.273,147.144,150.148,152.131,154.002,157.616,159.191,160.791,163.216,166.788,168.101,171.637,175.322,176.596,177.843,179.147,181.118,184.009,185.284,186.957,191.38,193.272,196.796,200.846,202.409,206.774,210.006,213.381,214.938,216.239,219.842,223.89200000000002,225.454,228.799,232.402,235.405,237.298,242.902,244.177,245.793,249.025,252.256,255.488,258.72,259.684,262.916,266.148,267.15,270.324,273.556" svgx:width="0.45,0.54,0.54,0.29,0.53,0.45,0.44,0.53,0.55,0.3,0.53,0.55,0.48,0.53,0.53,0.45,0.53,0.44,0.48,0.55,0.29,0.48,0.36,0.45,0.48,0.29,0.45,0.3,0.29,0.53,0.21,0.55,0.36,0.53,0.21,0.52,0.54,0.21,0.21,0.21,0.3,0.44,0.17,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.45,0.55,0.21,0.53,0.54,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">approach to enhance resveratrol solubility. Drug Dev Ind Pharm. 2014;40:102</text>
   <text y="267.815" x="276.772" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="267.815" x="280.174,283.349" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">9.</text>
   <text y="277.055" x="56.69,60.103,63.516,64.791,71.714,75.497,78.91,82.693,86.743,88.664,92.227,94.671,95.94600000000001,98.019,102.023,105.806,109.511,112.696,116.67099999999999,118.598,122.16,125.722,126.997,129.029" svgx:width="0.48,0.48,0.17,0.55,0.53,0.48,0.53,0.54,0.55,0.5,0.34,0.17,0.55,0.56,0.53,0.52,0.45,0.53,0.55,0.5,0.5,0.17,0.55,0.67" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">16. Zeng BJ, Chuan YP, O</text>
   <text y="277.055" x="133.793" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">’</text>
   <text y="277.055" x="134.983,138.247,141.952,143.434,144.916,146.398,149.582,152.767,156.742,158.737,162.3,163.57500000000002,165.597,169.601,172.786,178.571,180.053,183.837,186.43,189.544,193.327,194.902,196.947,198.429,199.704,201.766,204.951,208.135,211.919,215.702,219.407,223.45700000000002,225.406,230.892,235.345,236.62,238.672,241.935,245.719,249.502,255.287,258.472,261.17199999999997,263.22,266.782" svgx:width="0.46,0.52,0.21,0.21,0.21,0.45,0.45,0.53,0.55,0.5,0.17,0.55,0.56,0.45,0.81,0.21,0.53,0.36,0.44,0.53,0.21,0.55,0.21,0.17,0.55,0.45,0.45,0.53,0.53,0.52,0.54,0.55,0.77,0.63,0.17,0.55,0.46,0.53,0.53,0.81,0.45,0.36,0.55,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Sullivan B, Caminschi I, Lahoud MH, Thomas R,</text>
   <text y="286.069" x="71.714,77.2,78.682,82.537,86.392,89.804,91.286,95.141,98.554,100.627,104.67699999999999,106.636,110.79,114.353,116.796,118.07100000000001,120.129,123.691,127.104,130.218,133.63,137.485,139.637,143.42,145.493,147.567,150.16,154.015,157.428,160.541,162.023,163.876,165.358,168.65800000000002,170.584,174.439,177.852,179.334,180.816,184.001,187.413,189.487,192.787,194.792,198.575,200.52499999999998,202.559,206.413,208.487,212.27,214.422,217.835,219.317,223.292,225.235,228.42,232.203,234.355,235.837,239.692,243.105,247.07999999999998,249.046,251.198,255.173,257.096,260.951,264.364,268.147,272.002,274.075,275.557,277.709,279.191" svgx:width="0.77,0.21,0.54,0.54,0.48,0.21,0.54,0.48,0.29,0.54,0.55,0.58,0.5,0.34,0.17,0.55,0.5,0.48,0.44,0.48,0.54,0.3,0.53,0.29,0.29,0.36,0.54,0.48,0.44,0.21,0.26,0.21,0.44,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.53,0.26,0.55,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.55,0.45,0.53,0.3,0.21,0.54,0.48,0.53,0.55,0.3,0.53,0.55,0.54,0.48,0.53,0.54,0.29,0.21,0.3,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Middelberg APJ. Receptor-specific delivery of protein antigen to dendritic</text>
   <text y="295.084" x="71.714,74.828,78.241,79.723,81.205,83.905,85.944,89.799,93.099,95.015,98.39,100.344,104.128,107.312,111.096,114.879,118.292,124.077,127.782,129.264,131.858,133.34,137.123,140.906,144.69,146.542,150.325,152.399,158.184,161.597,165.64700000000002,167.637,171.342,173.935,175.417,179.201,183.251,185.211,187.363,191.146,195.001,197.074,200.929,204.712,209.828,213.803,215.768,219.551,223.334,227.118,229.191,232.305,236.088,239.273,242.458,243.94,247.352,251.136,253.386,255.452,258.566,260.048,261.529,264.643,267.79299999999995,269.738,272.332,275.744,277.226,279.079" svgx:width="0.44,0.48,0.21,0.21,0.36,0.55,0.54,0.44,0.55,0.45,0.55,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.53,0.26,0.53,0.29,0.81,0.48,0.54,0.55,0.52,0.36,0.21,0.53,0.54,0.55,0.3,0.53,0.54,0.29,0.54,0.53,0.72,0.53,0.55,0.53,0.53,0.53,0.29,0.44,0.53,0.45,0.45,0.21,0.48,0.53,0.3,0.55,0.44,0.21,0.21,0.44,0.42,0.55,0.36,0.48,0.21,0.26,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">cells by a nanoemulsionnformed using top-down non-covalent click self-</text>
   <text y="304.098" x="71.714,74.899,77.493,80.086,83.499,89.284,93.139,94.621,97.734,99.009,101.08,104.343,110.129,113.314,114.796,116.278,117.55300000000001,119.562,122.974,126.387,129.8,133.213,134.396,137.808,138.991,142.404,145.817,149.23" svgx:width="0.45,0.36,0.36,0.48,0.81,0.54,0.21,0.44,0.17,0.55,0.46,0.81,0.45,0.21,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">assembly. Small. 2013;9:3736</text>
   <text y="304.098" x="152.672" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="304.098" x="156.243,159.656,163.069" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">42.</text>
   <text y="313.338" x="56.691,60.104,63.516,64.791,71.714,76.089,79.274,83.057,85.209,88.584,90.536,93.799,95.07400000000001,97.112,101.266,107.052,108.534,110.016,111.59100000000001,113.666,119.153,120.42800000000001,122.454,126.458,130.241,133.426,137.281,143.066,144.548,148.331,149.813,152.407,154.558,156.632,159.817,161.968,163.45,167.234,171.209,173.193,176.976,178.926,180.96,184.814,187.999,191.113,192.595,194.077,196.228,199.413,202.456,205.868,207.44299999999998,209.532,212.717,216.5,220.55,222.458,225.572,229.277,231.35,234.463,238.168,243.954,245.436,249.411,251.371,252.853" svgx:width="0.48,0.48,0.17,0.55,0.61,0.45,0.53,0.3,0.45,0.55,0.46,0.17,0.55,0.58,0.81,0.21,0.21,0.21,0.55,0.77,0.17,0.55,0.56,0.53,0.45,0.54,0.81,0.21,0.53,0.21,0.36,0.3,0.29,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.54,0.45,0.44,0.21,0.21,0.3,0.45,0.43,0.48,0.21,0.55,0.45,0.53,0.54,0.55,0.44,0.52,0.29,0.44,0.52,0.81,0.21,0.53,0.55,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">17. Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in</text>
   <text y="322.353" x="71.714,75.498,78.682,82.466,86.249,89.662,95.447,99.152,100.634,103.228,104.71,108.493,112.46799999999999,114.403,116.256,120.039,122.112,127.898,131.603,133.085,136.269,138.421,139.903,143.687,147.47,150.17,152.216,154.368,158.343,160.323,164.106,167.291,170.704,172.777,175.891,179.674,185.46,189.06,190.993,196.778,200.483,201.965,204.117,205.599,209.454,211.527,215.232,219.282,221.267,223.34,226.753,229.346,230.828,233.422,235.573,238.758,242.542,245.655,249.255,251.2,252.682,256.657,258.627,260.779,264.483,270.269,274.052" svgx:width="0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.3,0.53,0.55,0.53,0.45,0.48,0.29,0.44,0.53,0.81,0.48,0.55,0.81,0.52,0.21,0.3,0.21,0.54,0.29,0.52,0.54,0.55,0.29,0.48,0.36,0.21,0.36,0.3,0.45,0.53,0.44,0.48,0.55,0.21,0.53,0.55,0.3,0.52,0.81,0.53,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">nanoemulsion formulations to overcome multidrug resistance in tumor</text>
   <text y="331.31" x="71.714,74.828,78.241,79.723,81.205,83.798,85.07300000000001,87.135,92.621,96.404,97.979,100.004,103.566,107.35,110.534,112.608,118.393,119.668,121.717,125.13,128.543,131.955,135.368,136.551,139.964,141.146,144.559,147.972" svgx:width="0.44,0.48,0.21,0.21,0.36,0.17,0.55,0.77,0.53,0.21,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">cells. Mol Pharm. 2009;6:928</text>
   <text y="331.31" x="151.425" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="331.31" x="154.94,158.352,161.765" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">39.</text>
   <text y="340.55" x="56.691,60.104,63.516,64.791,71.714,76.089,79.794,83.76899999999999,85.718,88.902,90.177,92.237,97.723,101.098,103.008,106.272,107.54700000000001,109.642,113.425,117.208,120.393,124.368,126.309,130.762,132.037,134.076,137.261,141.044,144.827,148.877,150.8,154.362,155.637,157.716,161.499,165.283,168.696,172.479,176.52900000000002,178.465,182.47,183.745,185.778,190.374,194.079,197.264,201.239,203.239,208.725,210.0,212.026,215.589,217.662,221.075,222.557,224.039,229.824,231.306,235.09,238.275,240.348,243.64800000000002,245.645,249.057,252.242,255.427,256.909,260.614,263.799,265.951,267.433,271.216,275.19100000000003,277.165,280.948,282.89799999999997,284.932" svgx:width="0.48,0.48,0.17,0.55,0.61,0.52,0.53,0.55,0.45,0.17,0.55,0.77,0.45,0.55,0.46,0.17,0.55,0.53,0.53,0.45,0.53,0.55,0.63,0.17,0.55,0.45,0.53,0.53,0.54,0.55,0.5,0.17,0.55,0.53,0.53,0.48,0.53,0.54,0.55,0.56,0.17,0.55,0.64,0.52,0.45,0.53,0.55,0.77,0.17,0.55,0.5,0.29,0.48,0.21,0.21,0.81,0.21,0.53,0.45,0.29,0.44,0.55,0.48,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">18. Guo L, Ma E, Zhao H, Long Y, Zheng C, Duan M. Preliminary evaluation of a</text>
   <text y="349.564" x="71.714,75.498,79.281,82.466,85.879,87.45400000000001,89.459,93.242,95.316,98.5,100.075,102.158,106.012,109.425,110.907,112.389,115.574,118.987,121.06,124.36,126.308,128.902,132.015,134.609,136.76,140.173,146.248,148.135,149.987,153.77,155.94500000000002,157.999,160.072,163.856,167.418,170.681,175.134,178.547,180.621,184.033,187.446" svgx:width="0.53,0.53,0.45,0.48,0.21,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.55,0.26,0.53,0.29,0.55,0.29,0.53,0.5,0.46,0.63,0.48,0.29,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">novel oral delivery system for rhPTH1-34:</text>
   <text y="349.564" x="190.77,192.174,195.999,197.913,200.877,202.281,204.354,206.356" svgx:width="0.2,0.51,0.55,0.42,0.2,0.29,0.28,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">In vitro</text>
   <text y="349.564" x="212.086,215.271,219.054" svgx:width="0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and</text>
   <text y="349.564" x="225.069,226.473,230.298,232.269,235.233,236.637,239.6" svgx:width="0.2,0.51,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">in vivo</text>
   <text y="349.564" x="243.154,244.429,246.5,247.982,251.765,254.015,256.024,258.574,260.616,264.179,267.962,271.147,273.22,279.005" svgx:width="0.17,0.55,0.21,0.53,0.3,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">. Int J Pharm.</text>
   <text y="358.579" x="71.714,75.127,78.54,81.953,85.366,86.548,89.961,93.374,96.787,97.97,101.382,104.795" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2011;420:172</text>
   <text y="358.579" x="108.168" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="358.579" x="111.74,115.153" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">9.</text>
   <text y="367.819" x="56.691,60.104,63.516,64.791,71.714,76.089,79.502,81.575,84.169,87.952,91.137,94.92,96.402,99.552,101.477,104.74,106.015,108.11,111.673,115.086,118.869,120.351,122.503,125.878,127.782,131.046,132.321,134.416,137.679,141.092,142.574,144.426,146.499,150.354,151.836,154.429,158.284,161.697,163.77,166.364,167.846,171.629,175.679,177.615,179.097,180.579,184.433,185.915,189.965,191.958,193.81,197.594,199.667,205.452,209.157,210.639,213.824,215.976,217.458,221.241,225.024,227.724,229.771,231.623,235.407,237.58200000000002,239.635,241.117,246.903,250.757,252.831,256.614,259.799,261.281,265.064,269.11400000000003,271.043,274.826,276.899,280.084" svgx:width="0.48,0.48,0.17,0.55,0.61,0.48,0.29,0.36,0.53,0.45,0.53,0.21,0.42,0.55,0.46,0.17,0.55,0.5,0.48,0.53,0.21,0.3,0.45,0.55,0.46,0.17,0.55,0.46,0.48,0.21,0.26,0.29,0.54,0.21,0.36,0.54,0.48,0.29,0.36,0.21,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.26,0.53,0.29,0.55,0.21,0.81,0.54,0.29,0.53,0.45,0.21,0.53,0.54,0.55,0.53,0.29,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">19. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral</text>
   <text y="376.833" x="71.714,74.899,78.754,81.347,85.131,87.204,91.058,93.21,94.692,98.475,102.44999999999999,104.368,108.152,110.102,112.192,113.674,115.156,119.011,122.794,126.649,130.432,131.914,133.396,134.878,138.178,140.141,143.996,146.069,149.774,153.629,156.222,157.497,159.529,162.793,166.498,168.673,170.755,173.305,175.29,178.853,182.636,185.821,187.894,193.969,195.869,199.432,200.914,204.697,208.552,212.335,215.52,217.593,223.379,224.654,226.709,230.122,233.535,236.948,240.361,241.543,244.956,248.369,249.552,252.965,256.378" svgx:width="0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.46,0.52,0.29,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50:179</text>
   <text y="376.833" x="259.765" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="376.833" x="263.337,266.75,270.163" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">88.</text>
   <text y="386.074" x="56.691,60.104,63.516,64.791,71.714,74.158,77.343,81.198,84.981,88.166,91.541,93.484,97.488,98.763,100.797,104.359,107.544,109.026,111.619,115.403,118.588,120.07,121.645,123.7,127.185,128.46,130.56,134.123,137.308,140.421,144.276,148.059,151.244,155.219,157.149,160.412,164.566,165.841,167.92,169.402,173.186,176.371,179.783,182.377,184.529,186.011,189.865,193.05,195.202,196.684,200.467,204.442,206.414,210.197,212.147,214.181,217.594,219.446,221.299,224.712,227.825,230.075,232.096,235.879,237.82899999999998,239.863,243.646,247.429,251.213,253.286,254.768,258.551,262.335,263.817" svgx:width="0.48,0.48,0.17,0.55,0.34,0.45,0.54,0.53,0.45,0.45,0.55,0.56,0.17,0.55,0.5,0.45,0.21,0.36,0.53,0.45,0.21,0.21,0.55,0.49,0.17,0.55,0.5,0.45,0.44,0.54,0.53,0.45,0.53,0.55,0.46,0.58,0.17,0.55,0.21,0.53,0.45,0.48,0.36,0.3,0.21,0.54,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.53,0.53,0.53,0.29,0.21,0.53,0.53,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">20. Jadhav C, Vaishali K, Payghan SA. Investigation of effect of non-ionic</text>
   <text y="395.088" x="71.714,74.308,78.013,80.086,81.939,85.123,88.237,90.389,93.574,97.357,99.607,101.647,105.431,109.40599999999999,111.342,115.196,117.27,120.682,124.537,127.722,129.795,132.98,135.132,136.614,140.397,144.37199999999999,146.377,150.16,152.10999999999999,154.144,157.998,160.072,161.554,164.147,167.56,171.343,173.196,176.901,178.383,181.567,183.049,187.024,189.009,192.793,196.576,200.359,202.433,205.618,209.472,213.177,216.59,220.373,224.078,226.778,228.807,232.59,235.775,239.558,243.342,246.755,252.54,256.245,257.727,260.32,261.802,265.586,269.369,270.644,272.686" svgx:width="0.36,0.52,0.29,0.26,0.45,0.44,0.3,0.45,0.53,0.3,0.55,0.53,0.53,0.55,0.54,0.29,0.48,0.54,0.45,0.29,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.54,0.29,0.21,0.36,0.48,0.53,0.26,0.52,0.21,0.45,0.21,0.53,0.55,0.53,0.53,0.53,0.29,0.45,0.54,0.52,0.48,0.53,0.52,0.36,0.55,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.17,0.55,0.34" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">surfactant on preparation of griseofulvin non-aqueous nanoemulsion. J</text>
   <text y="404.102" x="71.714,76.239,79.423,83.207,86.99,89.584,91.735,93.809,97.514,100.627,102.779,106.484,108.557,112.157,114.12,118.124,121.907,125.32,131.105,132.38,134.415,137.828,141.241,144.653,148.066,149.249,152.662,154.514,157.927,159.78,160.962,164.375,167.788" svgx:width="0.63,0.45,0.53,0.53,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.55,0.56,0.53,0.48,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Nanostructure Chem. 2015;5(1):107</text>
   <text y="404.102" x="171.211" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="404.102" x="174.782,178.195,181.608" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">13.</text>
   <text y="413.343" x="56.691,60.104,63.516,64.791,71.714,77.5,80.685,84.468,88.518,90.423,93.608,94.88300000000001,96.942,100.205,103.39,107.245,111.028,113.203,115.254,118.816,120.09100000000001,122.17,125.433,128.618,131.212,133.363,137.147,140.74699999999999,142.693,145.136,146.411,148.475,151.66,153.23499999999999,155.278,159.133,160.40800000000002,162.478,166.931,170.344,173.756,177.54,180.725,184.7,186.628,190.191,193.675,194.95000000000002,197.003,201.598,205.382,209.165,213.215,215.144,217.588,218.863,220.927,224.19,227.973,230.047,235.832,239.017,241.169,242.651,246.434,250.409,252.39,255.575,259.359,263.409,265.316,267.91,270.062,273.247,277.101,278.583,280.065,281.547,283.699" svgx:width="0.48,0.48,0.17,0.55,0.81,0.45,0.53,0.54,0.55,0.45,0.17,0.55,0.46,0.45,0.54,0.53,0.29,0.55,0.5,0.17,0.55,0.46,0.45,0.36,0.3,0.53,0.48,0.55,0.34,0.17,0.55,0.45,0.21,0.55,0.54,0.17,0.55,0.63,0.48,0.48,0.53,0.45,0.53,0.55,0.5,0.49,0.17,0.55,0.64,0.53,0.53,0.54,0.55,0.34,0.17,0.55,0.46,0.53,0.29,0.81,0.45,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.36,0.3,0.45,0.54,0.21,0.21,0.21,0.3,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">21. Wang L, Tabor R, Eastoe J, Li X, Heenan RK, Dong J. Formation and stability</text>
   <text y="422.3" x="71.714,75.498,77.44800000000001,79.481,83.264,86.449,90.233,94.016,97.429,103.214,106.919,108.401,110.995,112.477,116.26,120.043,122.74300000000001,124.778,129.893,131.375,133.527,137.50199999999998,139.461,145.246,146.728,149.77,153.183,157.233,159.19,160.672,164.455,168.238,169.72" svgx:width="0.53,0.26,0.55,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.72,0.21,0.3,0.53,0.55,0.81,0.21,0.43,0.48,0.54,0.55,0.21,0.53,0.53,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">of nanoemulsions with mixed ionic</text>
   <text y="422.3" x="172.854" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="422.3" x="176.369,180.152,183.936,187.719,189.201,192.984,196.768,198.25,201.55,203.524,206.118,209.823,211.896,213.749,216.933,220.047,222.199,225.383,229.167,231.319,233.912,235.187,237.256,240.818,244.601,247.715,250.415,252.449,256.453,260.236,263.649,269.724,271.611,275.615,279.398,282.811" svgx:width="0.53,0.53,0.53,0.21,0.53,0.53,0.21,0.44,0.55,0.36,0.52,0.29,0.26,0.45,0.44,0.3,0.45,0.53,0.3,0.36,0.17,0.55,0.5,0.53,0.44,0.36,0.55,0.56,0.53,0.48,0.81,0.55,0.56,0.53,0.48,0.81" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">nonionic surfactants. Phys Chem Chem</text>
   <text y="431.314" x="71.714,75.276,79.059,82.173,84.766,86.04100000000001,88.097,91.51,94.923,98.336,101.749,102.931,106.344,109.757,110.94,114.353,117.765,121.178" svgx:width="0.5,0.53,0.44,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Phys. 2009;11:9772</text>
   <text y="431.314" x="124.552" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="431.314" x="128.124,131.536" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">8.</text>
   <text y="440.555" x="56.69,60.103,63.516,64.791,71.714,75.497,79.28,82.465,86.248,90.298,92.236,94.68,95.95500000000001,98.019,101.204,104.579,106.522,110.085,111.36,113.382,117.165,120.949,124.134,128.109,130.106,133.37,134.645,136.683,142.468,145.653,149.436,153.48600000000002,155.448,159.01,160.285,162.307,165.571,168.755,172.73,174.666,180.152,181.427,183.51,187.365,188.847,192.447,194.395,198.848,200.12300000000002,202.162,205.347,208.722,210.666,215.04,216.315,218.375,223.862,227.237,229.204,233.058,234.333,236.404,239.667,241.519,243.372,246.785,249.898,252.148,254.148,257.931,259.881,261.972,263.454,264.936,268.791,272.574,274.056,277.169,279.763,281.245" svgx:width="0.48,0.48,0.17,0.55,0.53,0.53,0.45,0.53,0.54,0.55,0.34,0.17,0.55,0.45,0.45,0.55,0.5,0.17,0.55,0.53,0.53,0.45,0.53,0.55,0.46,0.17,0.55,0.81,0.45,0.53,0.54,0.55,0.5,0.17,0.55,0.46,0.45,0.53,0.55,0.77,0.17,0.55,0.54,0.21,0.48,0.55,0.63,0.17,0.55,0.45,0.45,0.55,0.61,0.17,0.55,0.77,0.45,0.55,0.54,0.17,0.55,0.46,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.21,0.44,0.36,0.21,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">22. Zhang J, Lv Y, Zhao S, Wang B, Tan M, Xie H, Lv G, Ma X. Effect of lipolysis</text>
   <text y="449.569" x="71.714,75.497,79.472,81.408,85.262,87.336,91.041,95.091,97.055,99.128,102.541,104.023,107.436,110.621,113.214,116.814,118.768,120.62,122.694,126.477,132.552,134.415,137.008,140.421,141.903,143.756,145.829,151.614,153.096,156.21,158.283,162.067,165.479,171.265,174.97,176.452,179.045,180.527,182.38,185.493,186.975,190.759,194.809,196.776,200.63,202.703,206.408,210.458,212.423,216.277,219.69,221.172,222.654,225.839,229.252,231.325,234.625,236.573,239.167,242.28,244.874,247.025,250.438,256.224,258.924,260.95,262.803,266.066,271.552,274.815,279.411,284.006,287.27" svgx:width="0.53,0.53,0.55,0.54,0.29,0.52,0.54,0.55,0.29,0.48,0.21,0.48,0.45,0.36,0.48,0.55,0.26,0.29,0.53,0.81,0.55,0.36,0.48,0.21,0.26,0.29,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.55,0.26,0.46,0.77,0.46,0.64,0.64,0.46,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">on drug release from self-microemulsifying drug delivery systems (SMEDDS)</text>
   <text y="458.583" x="71.714,76.829,78.311,80.463,84.43799999999999,86.34,90.195,91.677,93.529,95.382,98.795,100.868,104.281,108.064,110.314,112.418,115.532,119.315,121.388,124.801,127.245,129.839,133.622,137.035,138.517,140.09199999999998,142.125,145.979,148.053,151.758,155.80800000000002,157.772,159.254,163.037,166.151,169.335,171.487,172.969,176.752,180.536,181.811,183.85,188.003,192.157,195.72,199.17,201.14,204.703,208.486,211.671,213.744,219.53,222.793,225.906,227.388,230.652,234.064,237.178,240.961,242.23600000000002,244.282,247.695,251.108,254.521,257.934,259.116,262.529,265.942,267.125,270.538,273.95" svgx:width="0.72,0.21,0.3,0.53,0.55,0.54,0.21,0.26,0.26,0.48,0.29,0.48,0.53,0.3,0.55,0.44,0.53,0.29,0.48,0.34,0.36,0.53,0.48,0.21,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.21,0.53,0.44,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.58,0.58,0.5,0.46,0.55,0.5,0.53,0.45,0.29,0.81,0.46,0.44,0.21,0.46,0.48,0.44,0.53,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">with different core/shell drug location. AAPS PharmSciTech. 2014;15:731</text>
   <text y="458.583" x="277.396" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="458.583" x="280.968,284.38,287.793" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">40.</text>
   <text y="467.824" x="56.69,60.103,63.516,64.791,71.714,75.276,77.349,80.534,83.128,86.313,90.096,93.879,97.254,99.209,102.772,105.957,107.439,111.339,113.269,116.831,118.10600000000001,120.185,124.56,128.343,133.459,135.532,137.107,139.12,142.683,143.958,146.036,150.489,153.674,155.748,157.23,161.013,162.588,164.631,168.635,172.418,176.202,181.317,185.172,188.357,190.43,193.73000000000002,195.698,199.26,200.535,202.614,206.176,209.361,211.954,215.738,219.151,222.563,226.613,228.522,232.676,233.951,236.005,240.01,243.793,247.576,249.728,253.141,258.926,262.781,266.564,268.637,271.822,273.896" svgx:width="0.48,0.48,0.17,0.55,0.5,0.29,0.45,0.36,0.45,0.53,0.53,0.45,0.55,0.5,0.45,0.21,0.52,0.55,0.5,0.17,0.55,0.61,0.53,0.72,0.29,0.21,0.55,0.5,0.17,0.55,0.63,0.45,0.29,0.21,0.53,0.21,0.55,0.56,0.53,0.53,0.72,0.54,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.45,0.36,0.53,0.48,0.48,0.54,0.55,0.58,0.17,0.55,0.56,0.53,0.53,0.3,0.48,0.81,0.54,0.53,0.29,0.45,0.29,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">23. Prasanna Raju Y, Gowri Y, Harini Chowdary V, Rasheed A. Contemporary</text>
   <text y="476.838" x="71.714,74.307,76.459,78.532,81.717,83.869,87.282,91.136,92.618,96.031,98.73100000000001,100.74,102.222,106.19699999999999,108.167,111.58,117.365,121.07,122.552,125.145,126.627,128.48,129.962,133.375,137.425,139.404,143.258,145.332,149.037,153.08700000000002,154.994,158.848,162.261,163.743,165.225,168.41,171.823,173.896,177.196,179.201,181.795,184.908,187.502,189.653,193.066,198.852,201.445,202.72,204.769,208.144,210.098,212.172,215.585,217.736,219.81,223.593,226.186,230.041,233.454,236.567,238.719,240.201,243.386,246.986,248.932,252.715,255.9,259.313,261.386,264.571,266.053,269.466,274.582" svgx:width="0.36,0.3,0.29,0.45,0.3,0.48,0.54,0.21,0.48,0.36,0.55,0.21,0.53,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.21,0.48,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.45,0.55,0.29,0.48,0.3,0.29,0.53,0.36,0.54,0.48,0.44,0.3,0.21,0.45,0.48,0.55,0.53,0.45,0.48,0.29,0.45,0.21,0.48,0.72,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">strategies in emulsified drug delivery systems: a retrospective overview.</text>
   <text y="485.795" x="71.714,74.157,77.941,80.014,83.869,87.054,91.029,92.973,95.523,97.565,101.127,104.911,108.095,110.169,116.244,118.087,121.351,124.464,125.946,127.221,129.256,132.669,136.081,139.494,142.907,144.09,147.503,150.915,152.098,155.511" svgx:width="0.34,0.53,0.29,0.54,0.45,0.53,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Jordan J Pharm Sci. 2017;10:41</text>
   <text y="485.795" x="158.964" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="485.795" x="162.536,165.949,169.362" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">55.</text>
   <text y="495.092" x="56.69,60.103,63.516,64.791,71.714,75.342,76.929,79.14,83.051,86.236,90.195,91.77,94.617,98.188,99.46300000000001,102.327,106.863,110.151,115.366,116.848,120.412,123.712,126.478,130.731,132.006,134.869,137.313,140.652,144.564,148.419,150.006,153.981,156.696,160.381,161.656,164.463,168.148,172.003,175.801,178.069,181.924,185.899,188.671,192.753,194.028,196.892,200.52,204.375,207.607,211.657,214.41,218.038,220.59,221.865,224.729,226.316,230.171,233.403,234.885,238.733,241.454,243.041,246.896,250.87099999999998,253.586,257.498" svgx:width="0.48,0.48,0.17,0.55,0.5,0.21,0.3,0.53,0.45,0.53,0.21,0.55,0.49,0.17,0.55,0.63,0.45,0.72,0.21,0.48,0.44,0.55,0.58,0.17,0.55,0.34,0.45,0.53,0.53,0.21,0.53,0.55,0.5,0.17,0.55,0.5,0.53,0.52,0.3,0.53,0.53,0.55,0.56,0.17,0.55,0.5,0.53,0.44,0.54,0.55,0.5,0.34,0.17,0.55,0.21,0.53,0.44,0.21,0.52,0.36,0.21,0.53,0.53,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">24. Vithani K, Hawley A, Jannin V, Pouton C, Boyd BJ. Inclusion of</text>
   <text y="504.05" x="71.714,75.568,77.213,81.181,84.594,87.361,89.571,91.159,95.127,96.609,100.20899999999999,103.065,105.729,109.528,111.682,113.609,116.898,120.129,122.34,125.628,129.54,131.751,134.451,137.307,138.894,142.869,145.584,148.305,152.16,153.748,155.23,159.28,162.082,164.803,170.588,174.157,178.125,181.98,184.67999999999998,187.593,189.52,193.432,195.586,201.482,205.281,206.763,210.099,212.367,213.954,217.81,221.785,224.499,226.71,230.225,236.01,239.919,243.207,246.722,249.422,252.278,253.865,257.05,261.1,263.9,266.168,267.755,273.541" svgx:width="0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.54,0.21,0.48,0.55,0.36,0.52,0.29,0.26,0.45,0.44,0.3,0.45,0.53,0.3,0.36,0.55,0.21,0.53,0.55,0.36,0.53,0.21,0.21,0.54,0.55,0.36,0.81,0.48,0.54,0.54,0.36,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.29,0.48,0.81,0.53,0.45,0.48,0.36,0.55,0.21,0.45,0.54,0.55,0.3,0.21,0.81,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">digestible surfactants in solid smedds formulation removes lag time</text>
   <text y="513.064" x="71.714,74.898,78.857,82.907,85.66,87.142,91.103,93.03,94.594,98.381,101.875,105.741,108.973,112.385,115.08500000000001,117.987,120.255,124.12,127.72,130.47,132.404,136.316,138.471,144.257,147.599,149.867,151.431,155.296,159.271,162.042,165.898,167.84799999999998,170.66,173.381,175.615,177.826,181.612,184.808,187.076,190.874,193.029,196.524,200.574,203.327,207.182,210.527,212.681,214.949,216.536,219.732,221.296,224.791,227.49099999999999,230.29,234.258,238.057,240.212,241.776,245.641,249.691,252.444,256.412,258.0,261.854,265.427,268.102,270.37,271.934,275.799,279.665" svgx:width="0.45,0.53,0.54,0.55,0.21,0.53,0.26,0.21,0.52,0.48,0.53,0.44,0.48,0.36,0.55,0.3,0.53,0.48,0.55,0.26,0.53,0.29,0.81,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.54,0.55,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.36,0.55,0.54,0.52,0.29,0.21,0.53,0.54,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and influences the formation of structured particles during digestion.</text>
   <text y="522.078" x="71.714,75.867,80.161,83.833,87.283,90.012,92.566,93.84100000000001,96.705,100.227,103.64,107.201,110.715,111.963,115.485,119.008,120.3,123.713,127.274" svgx:width="0.58,0.58,0.5,0.46,0.55,0.34,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">AAPS J. 2017;19:754</text>
   <text y="522.078" x="130.788" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="522.078" x="134.416,137.931,141.446" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">64.</text>
   <text y="531.318" x="56.69,60.103,63.516,64.791,71.714,75.867,78.682,82.095,85.507,91.58200000000001,93.427,97.581,98.85600000000001,100.91,104.472,105.954,108.769,113.884,117.069,121.044,122.963,128.449,129.72400000000002,131.807,135.961,139.744,145.53,148.715,152.76500000000001,154.711,157.974,160.418,161.693,163.725,165.207,169.061,172.916,176.101,177.676,179.768,183.552,184.827,186.855,190.339,194.122,197.307,199.482,201.538,205.1,208.584,209.859,211.912,216.066,219.921,221.403,222.97799999999998,225.008,230.494,231.769,233.852,237.115,240.3,241.782,245.195,249.05,252.234,256.018,259.801,262.765,265.95,268.125,270.191,273.454" svgx:width="0.48,0.48,0.17,0.55,0.58,0.4,0.48,0.48,0.81,0.55,0.58,0.17,0.55,0.5,0.21,0.4,0.72,0.45,0.53,0.55,0.77,0.17,0.55,0.58,0.53,0.81,0.45,0.54,0.55,0.46,0.34,0.17,0.55,0.21,0.54,0.54,0.45,0.21,0.55,0.53,0.17,0.55,0.49,0.53,0.45,0.29,0.55,0.5,0.49,0.17,0.55,0.58,0.54,0.21,0.21,0.55,0.77,0.17,0.55,0.46,0.45,0.21,0.48,0.54,0.45,0.53,0.53,0.42,0.45,0.29,0.55,0.46,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">25. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, Talegaonkar S.</text>
   <text y="540.333" x="71.714,76.238,79.423,83.206,86.989,90.402,96.188,99.893,101.375,103.968,105.45,109.233,113.208,115.139,118.253,122.036,127.821,131.676,135.459,139.243,142.656,146.439,148.591,151.291,153.349,155.943,159.056,161.13,164.543,167.955,171.739,173.221,177.004,181.054,182.999,186.184,189.967,194.01700000000002,195.981,198.575,201.987,203.469,206.882,209.996,212.148,213.63,217.413,221.196,222.471,224.497,227.872,229.827,231.978,235.391,238.505,242.288,246.071,247.553,250.667,253.852,255.427,257.492,261.275,265.059,267.21,270.623,271.89799999999997,273.933,278.086,282.24,285.803" svgx:width="0.63,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.44,0.53,0.81,0.54,0.53,0.53,0.48,0.53,0.3,0.36,0.55,0.36,0.44,0.29,0.48,0.48,0.53,0.21,0.53,0.54,0.55,0.45,0.53,0.54,0.55,0.36,0.48,0.21,0.48,0.44,0.3,0.21,0.53,0.53,0.17,0.55,0.45,0.55,0.3,0.48,0.44,0.53,0.53,0.21,0.44,0.45,0.21,0.55,0.53,0.53,0.3,0.48,0.17,0.55,0.58,0.58,0.5,0.46" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Nanoemulsion components screening and selection: a technical note. AAPS</text>
   <text y="549.347" x="71.714,75.276,79.059,82.244,84.318,90.393,92.236,95.499,98.613,100.188,102.214,105.477,108.89,112.003,115.787,117.06200000000001,119.108,122.521,125.933,129.346,132.759,133.942,137.355,140.767,141.95,145.363" svgx:width="0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.55,0.46,0.48,0.44,0.53,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharm Sci Tech. 2009;10:69</text>
   <text y="549.347" x="148.816" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="549.347" x="152.388,155.801,159.214" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">76.</text>
   <text y="558.587" x="56.69,60.103,63.516,64.791,71.714,76.167,79.351,81.425,82.907,86.69,88.265,90.308,94.312,98.096,101.879,106.995,110.849,114.034,116.107,119.407,121.375,124.937,126.212,128.235,131.797,133.871,137.055,139.649,142.834,146.617,150.4,153.775,155.787,159.349,162.534,164.016,167.916,169.846,173.409,174.684,176.706,180.269,183.453,186.047,189.232,192.417,195.829,198.423,203.539,206.723,208.797,212.172,214.18,217.742,220.927,224.902,226.878,232.364,235.927,237.202,239.237,242.5,246.205,249.989,253.843,257.028,259.101,262.514,265.108,268.293,272.26800000000003,274.216,278.22,281.783" svgx:width="0.48,0.48,0.17,0.55,0.63,0.45,0.29,0.21,0.53,0.21,0.55,0.56,0.53,0.53,0.72,0.54,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.29,0.45,0.36,0.45,0.53,0.53,0.45,0.55,0.5,0.45,0.21,0.52,0.55,0.5,0.17,0.55,0.5,0.45,0.36,0.45,0.45,0.48,0.36,0.72,0.45,0.29,0.45,0.55,0.5,0.45,0.53,0.55,0.77,0.5,0.17,0.55,0.46,0.52,0.53,0.54,0.45,0.29,0.48,0.36,0.45,0.53,0.55,0.56,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">26. Harini Chowdary V, Prasanna Raju Y, Basaveswara Rao MV, Sundaresan CR.</text>
   <text y="567.544" x="71.714,73.196,76.979,79.572,81.054,84.909,88.692,90.844,93.544,95.581,99.364,101.31400000000001,103.347,109.133,110.615,113.728,115.802,119.585,122.998,128.783,132.488,133.97,136.564,138.046,141.829,145.612" svgx:width="0.21,0.53,0.36,0.21,0.54,0.53,0.3,0.36,0.55,0.53,0.26,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Insights of microemulsions</text>
   <text y="567.544" x="150.347" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="567.544" x="156.073,159.448,161.403,163.554,167.338,170.75,172.824,178.609,182.393,186.247,189.361,193.144,196.329,202.114,203.596,206.89600000000002,208.854,211.967,215.751,221.536,225.391,227.464,230.877,234.66,238.073,241.856,244.45,245.932,249.715,253.498,254.773,256.815,259.259,263.042,265.115,268.97,272.155,276.13,278.131" svgx:width="0.45,0.55,0.3,0.53,0.48,0.29,0.81,0.53,0.54,0.44,0.53,0.45,0.81,0.21,0.44,0.55,0.44,0.53,0.81,0.54,0.29,0.48,0.53,0.48,0.53,0.36,0.21,0.53,0.53,0.17,0.55,0.34,0.53,0.29,0.54,0.45,0.53,0.55,0.34" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">a thermodynamic comprehension. Jordan J</text>
   <text y="576.559" x="71.714,75.276,79.059,82.244,84.318,90.393,92.236,95.499,98.613,100.095,101.37,103.404,106.817,110.23,113.643,117.056,118.238,121.651,125.064,126.247,129.66" svgx:width="0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharm Sci. 2017;10:23</text>
   <text y="576.559" x="133.112" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="576.559" x="136.627,140.04,143.453" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">40.</text>
   <text y="585.799" x="56.69,60.103,63.516,64.791,71.714,74.977,78.76,81.945,84.909,88.322,91.735,93.31,95.354,98.617,99.89200000000001,101.93,106.084,107.566,110.751,114.534,117.719,120.533,122.108,124.154,127.417,130.901,132.17600000000002,134.245,138.398,139.88,142.474,145.659,147.732,149.805,153.18,155.164,156.646,160.8,162.07500000000002,164.121,168.575,171.759,175.809,177.728,182.252,183.52700000000002,185.608,188.871,192.655,194.137,197.841,201.696,203.178,204.66,206.142,208.956,212.141,214.293,215.775,219.558,223.533,225.519,229.373,232.786,236.57,239.754,242.939,244.421,248.205,250.38000000000002,252.39,256.174" svgx:width="0.48,0.48,0.17,0.55,0.46,0.53,0.45,0.42,0.48,0.48,0.21,0.55,0.46,0.17,0.55,0.58,0.21,0.45,0.53,0.45,0.4,0.21,0.55,0.46,0.49,0.17,0.55,0.58,0.21,0.36,0.45,0.29,0.29,0.45,0.55,0.21,0.58,0.17,0.55,0.63,0.45,0.54,0.55,0.63,0.17,0.55,0.46,0.53,0.21,0.52,0.54,0.21,0.21,0.21,0.4,0.45,0.3,0.21,0.53,0.53,0.55,0.54,0.48,0.53,0.45,0.45,0.21,0.53,0.29,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">27. Shakeel F, Alanazi FK, Alsarra IA, Haq N. Solubilization behavior of</text>
   <text y="594.813" x="71.714,75.568,78.753,80.826,84.011,87.125,90.538,92.689,95.874,101.66,105.443,107.018,109.073,110.555,114.53,116.443,118.595,120.668,123.853,127.636,130.23,133.343,137.048,139.2,142.983,144.465,146.539,151.654,154.839,156.991,160.404,162.579,164.688,170.473,171.955,174.998,177.149,180.854,182.928,186.34,189.04,191.049,194.234,196.484,198.533,200.385,203.798,207.211,210.623,211.806,215.219,218.819,220.812,222.964,226.939,228.863,232.275,235.688,239.101,240.284,243.697,247.109,249.059,251.086,254.57,257.014,258.289,260.383,264.387,268.171,271.583,277.658,279.489,282.752,286.535" svgx:width="0.54,0.45,0.29,0.45,0.44,0.48,0.3,0.45,0.81,0.53,0.21,0.55,0.21,0.53,0.55,0.3,0.29,0.45,0.53,0.36,0.44,0.52,0.3,0.53,0.21,0.29,0.72,0.45,0.3,0.48,0.29,0.55,0.81,0.21,0.43,0.3,0.52,0.29,0.48,0.36,0.55,0.45,0.3,0.55,0.26,0.48,0.48,0.48,0.17,0.48,0.48,0.55,0.3,0.53,0.55,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.55,0.49,0.34,0.17,0.55,0.56,0.53,0.48,0.81,0.55,0.46,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">paracetamol in transcutol-water mixtures at (298.15 to 333.15) KJ. Chem Eng</text>
   <text y="603.828" x="71.714,76.309,79.494,81.646,84.831,86.10600000000001,88.154,91.567,94.98,98.393,101.806,102.988,106.401,109.814,110.997,114.41,117.822,121.235" svgx:width="0.64,0.45,0.3,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Data. 2013;58:3551</text>
   <text y="603.828" x="124.665" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="603.828" x="128.18,131.593" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">6.</text>
   <text y="613.068" x="56.69,60.103,63.516,64.791,71.714,75.059,78.914,81.069,83.79,86.0,89.912,93.325,95.5,98.416,100.967,104.312,105.587,108.451,109.933,113.894,116.105,119.619,122.284,124.552,126.139,129.995,133.283,134.85799999999998,137.704,143.6,147.399,150.573,152.161,156.016,158.71599999999998,161.572,163.16,167.135,169.849,173.761,177.174,180.507,182.095,184.363,188.338,191.052,194.34,198.196,202.246,204.998,208.967,210.554,213.219,216.734,220.022,222.687,226.201,227.476,230.34,234.936,236.577,240.545,244.06,246.725,248.936,250.523,254.435,258.29,259.565,262.429,265.842,269.402,272.917,276.431,277.679,281.194,284.708" svgx:width="0.48,0.48,0.17,0.55,0.46,0.53,0.29,0.36,0.3,0.53,0.48,0.29,0.55,0.34,0.46,0.17,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.81,0.52,0.44,0.21,0.53,0.36,0.55,0.21,0.53,0.55,0.53,0.48,0.45,0.21,0.3,0.53,0.55,0.45,0.53,0.54,0.55,0.54,0.21,0.36,0.48,0.45,0.36,0.48,0.17,0.55,0.64,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">28. Forstner JF. Intestinal mucins in health and disease. Digestion. 1978;17:</text>
   <text y="622.082" x="71.714,75.126,78.687" svgx:width="0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">234</text>
   <text y="622.082" x="82.201" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="622.091" x="85.833,89.348,92.863" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">63.</text>
   <text y="631.332" x="56.693,60.106,63.519,64.794,71.717,76.17,79.354,81.428,82.91,86.693,88.268,90.311,94.315,98.099,101.882,106.998,110.852,114.037,116.11,119.41,121.378,124.94,126.215,128.238,131.8,133.873,137.058,139.652,142.837,146.62,150.403,153.778,155.79,159.352,162.537,164.019,167.919,169.849,173.412,174.687,176.709,180.272,183.976,187.831,189.313,192.688,194.68,198.243,201.427,204.021,209.806,213.219,216.632,220.607,222.573,226.135,227.41,229.433,231.876,235.061,238.175,241.36,243.953,246.027,247.60199999999998,249.672,253.234,254.50900000000001,256.588,260.15,263.563,266.677,270.089,273.944,276.096,279.879,281.952" svgx:width="0.48,0.48,0.17,0.55,0.63,0.45,0.29,0.21,0.53,0.21,0.55,0.56,0.53,0.53,0.72,0.54,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.29,0.45,0.36,0.45,0.53,0.53,0.45,0.55,0.5,0.45,0.21,0.52,0.55,0.5,0.17,0.55,0.5,0.52,0.54,0.21,0.45,0.55,0.5,0.45,0.36,0.81,0.48,0.48,0.53,0.55,0.5,0.17,0.55,0.34,0.45,0.44,0.45,0.36,0.29,0.21,0.55,0.5,0.17,0.55,0.5,0.48,0.44,0.48,0.54,0.3,0.53,0.29,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">29. Harini Chowdary V, Prasanna Raju Y, Rubia Yasmeen B, Jayasri V. Receptors</text>
   <text y="640.346" x="71.717,74.901,78.685,82.735,84.643,86.125,87.606,91.461,94.646,98.429,102.284,104.98400000000001,107.036,109.109,112.893,114.375,117.975,119.962,121.444,125.419,127.332,130.446,134.229,135.711,139.494,143.469,145.417,149.271,153.054,156.168,158.761,160.243,164.027,165.509,169.292,173.147,176.447,178.411,181.596,185.379,189.429,191.394,195.248,198.433,200.585,204.368,208.151,209.633,213.417,217.271,220.385,221.66,223.764,226.31400000000002,228.3,231.862,235.275,238.389,241.801,245.656,247.906,249.956,253.219,254.701,258.556,262.339,265.524" svgx:width="0.45,0.53,0.54,0.55,0.21,0.21,0.54,0.45,0.53,0.54,0.36,0.55,0.29,0.53,0.21,0.48,0.55,0.21,0.53,0.55,0.44,0.53,0.21,0.53,0.53,0.55,0.54,0.53,0.44,0.36,0.21,0.53,0.21,0.53,0.54,0.44,0.55,0.45,0.53,0.54,0.55,0.54,0.45,0.3,0.53,0.53,0.21,0.53,0.54,0.44,0.17,0.55,0.34,0.55,0.5,0.48,0.44,0.48,0.54,0.3,0.55,0.46,0.21,0.54,0.53,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and ligands role in colon physiology and pathology. J Recept Signal</text>
   <text y="649.304" x="71.717,74.98,77.053,80.238,84.021,86.615,90.469,94.174,97.288,99.44,100.715,102.783,106.196,109.609,113.022,116.435,117.617,121.03,124.443,125.626" svgx:width="0.46,0.29,0.45,0.53,0.36,0.54,0.52,0.44,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Transduct. 2013;33:1</text>
   <text y="649.304" x="129.033" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="649.304" x="132.605,136.018" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">9.</text>
   <text y="658.602" x="56.693,60.106,63.519,64.794,71.717,75.279,78.692,80.765,84.178,86.992,89.066,92.628,94.11,95.592,98.777,100.952,103.011,105.454,106.729,108.736,113.189,114.671,116.153,117.72800000000001,119.791,123.354,124.629,126.707,129.97,133.754,137.35399999999998,139.293,141.886,144.038,146.111,149.816,152.93,155.081,158.786,160.86,164.46,166.391,169.576,173.36,177.41000000000003,179.374,182.559,185.152,187.746,191.158,196.944,200.798,202.28,205.58,207.55,211.333,213.283,215.317,217.91,221.323,224.437,226.51,229.923,232.075,235.487,239.537,241.509,247.294,250.999,254.113,255.595,259.378,261.971,263.246,265.319,267.869,269.911,273.474,274.956,278.739" svgx:width="0.48,0.48,0.17,0.55,0.5,0.48,0.29,0.48,0.4,0.29,0.5,0.21,0.21,0.45,0.29,0.55,0.34,0.17,0.55,0.63,0.21,0.21,0.21,0.55,0.5,0.17,0.55,0.46,0.53,0.48,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.55,0.45,0.53,0.54,0.55,0.45,0.36,0.36,0.48,0.81,0.54,0.21,0.44,0.55,0.53,0.26,0.55,0.36,0.48,0.44,0.29,0.48,0.3,0.48,0.54,0.55,0.81,0.52,0.44,0.21,0.53,0.36,0.17,0.55,0.34,0.55,0.5,0.21,0.53,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">30. Perez-Vilar J, Hill R. The structure and assembly of secreted mucins. J Biol</text>
   <text y="667.559" x="71.717,75.721,79.504,82.917,88.702,89.977,92.012,95.425,98.837,102.25,105.663,106.846,110.259,113.672,117.084,118.267,121.68,125.093,128.506,131.918" svgx:width="0.56,0.53,0.48,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Chem. 1999;274:31751</text>
   <text y="667.559" x="135.326" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="667.559" x="138.898,142.311" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">4.</text>
   <text y="676.8" x="56.693,60.106,63.519,64.794,71.717,76.091,79.796,85.87100000000001,87.703,90.147,93.71,94.985,97.058,101.511,102.993,106.106,109.07,111.77,113.782,116.226,122.011,123.286,125.347,128.61,133.726,136.911,138.393,139.875,143.658,149.058,150.915,155.51,160.997,162.27200000000002,164.351,167.536,170.721,174.575,177.76,180.874,184.474,186.461,190.023,193.208,194.483,196.496,200.058,203.172,205.245,209.29500000000002,211.236,213.679,217.684,218.959,221.043,224.228,227.413,233.198,237.053,240.836,242.909,245.159,247.235,251.83,255.094,256.36899999999997,258.403,261.666,263.148,267.003,270.858,272.339,275.303,276.878,278.926,282.488" svgx:width="0.48,0.48,0.17,0.55,0.61,0.52,0.81,0.55,0.34,0.5,0.17,0.55,0.63,0.21,0.44,0.42,0.36,0.55,0.34,0.81,0.17,0.55,0.46,0.72,0.45,0.21,0.21,0.53,0.72,0.55,0.64,0.77,0.17,0.55,0.45,0.45,0.54,0.45,0.44,0.48,0.55,0.5,0.45,0.17,0.55,0.5,0.44,0.29,0.54,0.55,0.34,0.56,0.17,0.55,0.45,0.45,0.81,0.54,0.53,0.29,0.3,0.55,0.64,0.46,0.17,0.55,0.46,0.21,0.54,0.54,0.21,0.42,0.21,0.55,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">31. Gum JR, Hicks JW, Swallow DM, Lagace RL, Byrd JC, Lamport DT, Siddiki B,</text>
   <text y="685.814" x="71.717,75.201,76.683,82.75800000000001,84.586,88.148,91.411,92.686,94.734,100.22,104.003,105.485,108.898,112.011,115.716,117.198,120.383,122.55799999999999,124.61,127.723,129.205,132.989,136.772,138.254,142.037,146.08700000000002,148.024,151.807,153.75699999999998,155.847,158.961,163.557,168.081,172.235,174.935,176.937,180.792,184.204,186.278,187.76,190.945,194.357,198.407,200.407,202.26,204.333,208.116,215.998,219.373,221.327,225.111,228.894,232.079,235.492,237.06699999999998,239.128,242.912,246.616,252.402,255.587,259.562,261.522,263.004,266.787,268.939,272.352,274.945,277.097,278.579,282.362,285.547" svgx:width="0.49,0.21,0.81,0.55,0.5,0.46,0.17,0.55,0.77,0.53,0.21,0.48,0.44,0.52,0.21,0.45,0.29,0.55,0.44,0.21,0.53,0.53,0.21,0.53,0.54,0.55,0.53,0.26,0.55,0.44,0.64,0.63,0.58,0.36,0.55,0.54,0.48,0.29,0.21,0.45,0.48,0.54,0.55,0.26,0.29,0.53,0.81,0.45,0.55,0.53,0.53,0.45,0.48,0.21,0.55,0.53,0.52,0.81,0.45,0.53,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Kim YS. Molecular cloning of cDNAs derived froma novel human intestinal</text>
   <text y="694.828" x="71.717,77.502,81.207,84.32,85.802,89.777,91.729,95.584,98.996,102.78,106.192,107.467,109.474,113.036,114.518,118.301,121.415,125.198,128.611,134.68599999999998,136.572,140.135,141.617,145.4,149.255,153.038,156.152,158.85199999999998,160.893,164.456,167.868,170.56799999999998,172.572,176.576,180.359,186.145,191.93,195.635,199.418,200.693,202.788,206.201,209.614,213.027,216.44,217.622,221.035,224.448,227.861,229.044,232.456,235.869" svgx:width="0.81,0.52,0.44,0.21,0.53,0.55,0.54,0.48,0.53,0.48,0.17,0.55,0.5,0.21,0.53,0.44,0.53,0.48,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.44,0.36,0.55,0.5,0.48,0.36,0.55,0.56,0.53,0.81,0.81,0.52,0.53,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">mucin gene. Biochem Biophys Res Commun. 1990;171:407</text>
   <text y="694.828" x="239.301" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="694.828" x="242.816,246.229,249.642" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">15.</text>
   <text y="704.069" x="56.693,60.106,63.519,64.794,71.717,76.312,79.725,82.689,85.653,89.066,91.241,93.259,95.703,96.97800000000001,99.042,102.604,106.388,108.981,111.575,114.987,118.96199999999999,120.925,123.368,129.154,133.308,134.583,136.628,140.19,143.895,145.377,146.859,150.272,152.447,154.486,158.939,163.093,164.368,166.391,169.654,171.136,174.919,178.332,180.405,184.189,187.374,191.157,195.20700000000002,197.175,201.328,207.114,211.118,212.393,214.465,217.729,221.512,225.112,227.051,232.537,236.99,241.19,243.152,245.004,248.189,253.974,255.456,256.938,260.052,261.327,263.391,266.576" svgx:width="0.48,0.48,0.17,0.55,0.64,0.48,0.42,0.42,0.48,0.29,0.55,0.34,0.17,0.55,0.5,0.53,0.36,0.36,0.48,0.53,0.55,0.34,0.81,0.58,0.17,0.55,0.5,0.52,0.21,0.21,0.48,0.29,0.55,0.63,0.58,0.17,0.55,0.46,0.21,0.53,0.48,0.29,0.53,0.45,0.53,0.54,0.55,0.58,0.81,0.56,0.17,0.55,0.46,0.53,0.48,0.55,0.77,0.63,0.56,0.55,0.26,0.45,0.81,0.21,0.21,0.44,0.17,0.55,0.45,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">32. Dekker J, Rossen JWA, Büller HA, Einerhand AWC. The MUC family: an</text>
   <text y="713.083" x="71.717,75.5,79.354,80.836,82.988,86.693,89.878,91.951,95.065,96.34,98.362,101.625,103.698,107.111,110.894,114.749,117.449,119.508,123.07,124.552,128.335,131.449,135.232,138.645,144.72,146.606,149.87,152.983,154.465,155.74,157.775,161.187,164.6,168.013,171.426,172.609,176.022,179.434,180.617,184.03,187.443" svgx:width="0.53,0.54,0.21,0.3,0.52,0.45,0.29,0.44,0.17,0.55,0.46,0.29,0.48,0.53,0.54,0.36,0.55,0.5,0.21,0.53,0.44,0.53,0.48,0.81,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">obituary. Trends Biochem Sci. 2002;27:126</text>
   <text y="713.083" x="190.885" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="713.083" x="194.4,197.813,201.226" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">31.</text>
   <text y="722.324" x="56.693,60.106,63.519,64.794,71.717,75.201,76.683,82.75800000000001,84.586,88.148,91.411,92.686,94.734,99.108,102.813,108.888,110.72,113.164,116.727,118.00200000000001,120.075,124.67,126.152,129.337,132.75,134.823,137.417,138.899,141.05,144.35000000000002,146.323,150.106,152.05599999999998,154.09,159.875,163.58,166.694,168.176,172.15099999999998,174.102,177.957,181.369,185.153,188.566,191.159,192.434,194.511,197.105,199.257,201.33,205.035,208.148,210.3,214.005,216.078,219.491,220.76600000000002,222.857,224.71,228.414,232.198,235.311,237.463,238.945,242.728,246.512,247.787,249.842,253.027,256.81" svgx:width="0.48,0.48,0.17,0.55,0.49,0.21,0.81,0.55,0.5,0.46,0.17,0.55,0.61,0.52,0.81,0.55,0.34,0.5,0.17,0.55,0.64,0.21,0.45,0.48,0.29,0.36,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.81,0.52,0.44,0.21,0.53,0.55,0.54,0.48,0.53,0.48,0.36,0.17,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.17,0.55,0.26,0.52,0.53,0.44,0.3,0.21,0.53,0.53,0.17,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">33. Kim YS, Gum JR. Diversity of mucin genes, structure, function, and</text>
   <text y="731.338" x="71.717,75.129,78.172,82.026,84.1,87.512,90.106,92.699,94.181,97.965,101.748,103.02300000000001,105.051,109.426,112.611,115.204,117.356,119.429,123.212,126.625,130.409,132.56,135.973,138.046,141.83,143.312,144.58700000000002,146.663,150.075,153.488,156.901,160.314,161.497,164.91,168.322,171.735,172.918,176.331,179.744" svgx:width="0.48,0.43,0.54,0.29,0.48,0.36,0.36,0.21,0.53,0.53,0.17,0.55,0.61,0.45,0.36,0.3,0.29,0.53,0.48,0.53,0.3,0.48,0.29,0.53,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">expression. Gastroenterol. 1995;109:999</text>
   <text y="731.338" x="183.175" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="731.338" x="186.747,190.159,193.572,196.985,200.398" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">1001.</text>
   <text y="95.357" x="304.725,308.138,311.551,312.82599999999996,319.749,323.753,327.536,329.609,331.462,332.944,336.357,337.839,341.889,343.843,347.997,351.559,352.834,354.841,360.327,363.441,366.853,368.927,371.52,374.634,378.417,382.122,385.977,389.952,391.917,396.442,397.717,399.798,402.982,406.766,410.549,414.404,420.189,423.374,427.34900000000005,429.278,432.84,434.11499999999995,436.194,439.457,442.571,444.053,447.237,450.65,453.244,455.395,458.808,460.983,463.009,466.572,467.847,469.925,474.079,476.152,479.857,481.432,483.475,486.738,488.013,490.051,493.613,495.095,498.95,502.733,505.918,508.07,511.483,512.965,514.447,516.022,518.113,523.599" svgx:width="0.48,0.48,0.17,0.55,0.56,0.53,0.29,0.26,0.21,0.48,0.21,0.54,0.55,0.58,0.5,0.17,0.55,0.77,0.44,0.48,0.29,0.36,0.44,0.53,0.52,0.54,0.53,0.55,0.63,0.17,0.55,0.45,0.53,0.53,0.54,0.81,0.45,0.53,0.55,0.5,0.17,0.55,0.46,0.44,0.21,0.45,0.48,0.36,0.3,0.48,0.29,0.55,0.5,0.17,0.55,0.58,0.29,0.52,0.21,0.55,0.46,0.17,0.55,0.5,0.21,0.54,0.53,0.45,0.3,0.48,0.21,0.21,0.21,0.55,0.77,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">34. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M.</text>
   <text y="104.314" x="319.749,325.235,328.94,332.053,333.535,337.319,340.019,342.028,345.213,348.996,353.046,355.01,360.796,364.501,367.614,371.398,373.991,377.176,378.751,380.805,384.66,386.733,390.517,392.668,396.081,399.195,401.347,402.829,406.612,410.58700000000005,412.553,414.035,418.01000000000005,419.98,422.131,425.915,429.51500000000004,431.431,435.286,438.471,441.064,443.216,445.289,449.073,450.555,454.338,456.49,459.903,462.496,464.648,466.13,469.913,473.098,474.673,476.728,478.88,480.953,484.138,487.252,489.403,490.678,492.772,496.555,499.968,505.368,507.228,511.083,513.156,516.94,519.533,523.388,526.8,529.914,532.066" svgx:width="0.77,0.52,0.44,0.21,0.53,0.36,0.55,0.45,0.53,0.54,0.55,0.81,0.52,0.44,0.53,0.36,0.45,0.21,0.55,0.54,0.29,0.53,0.3,0.48,0.44,0.3,0.21,0.53,0.53,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.36,0.3,0.29,0.53,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.3,0.29,0.45,0.44,0.3,0.17,0.55,0.53,0.48,0.72,0.55,0.54,0.29,0.53,0.36,0.54,0.48,0.44,0.3,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Mucins and mucosal protection in the gastrointestinal tract: new prospects</text>
   <text y="113.328" x="319.749,321.601,325.384,327.559,329.556,335.341,339.046,342.16,343.642,347.425,350.125,352.176,353.658,357.63300000000004,359.603,361.755,365.538,369.13800000000003,371.055,374.91,378.094,380.246,384.029,387.813,389.295,393.078,396.933,400.233,402.236,406.019,407.969,410.003,413.857,417.042,419.635,421.787,423.861,427.644,429.126,432.909,435.061,438.474,441.067,443.219,444.701,448.484,451.669,453.24399999999997,455.299,459.154,460.636,463.229,466.642,469.827,472.42,475.833,477.108,479.166,483.541,487.246,489.398,490.673,492.772,496.185,499.598,503.011,506.423,507.606,511.019,514.432,515.615,519.027,522.44" svgx:width="0.26,0.53,0.29,0.55,0.81,0.52,0.44,0.21,0.53,0.36,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.3,0.53,0.53,0.21,0.53,0.54,0.44,0.55,0.53,0.26,0.55,0.54,0.45,0.36,0.3,0.29,0.53,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.54,0.21,0.36,0.48,0.45,0.36,0.48,0.17,0.55,0.61,0.52,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">for mucins in the pathology of gastrointestinal disease. Gut. 2000;47:589</text>
   <text y="113.328" x="525.828" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="113.328" x="529.399,532.812,536.225" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">94.</text>
   <text y="122.569" x="304.725,308.138,311.551,312.82599999999996,319.749,323.753,327.536,329.609,331.462,332.944,336.357,337.839,341.889,343.843,347.997,351.559,352.834,354.841,360.327,364.032,367.146,368.628,372.411,375.004,376.279,378.368,381.743,383.697,387.552,389.034,392.817,394.299,398.083,401.937,403.419,406.533,409.718,411.2,412.681,415.981,417.939,420.012,423.425,424.907,428.32,431.505,434.69,438.473,440.723,442.77,446.625,448.107,451.22,454.334,457.519,461.494,463.463,467.317,470.502,472.576,474.649,476.131,479.544,481.719,483.758,485.24,489.21500000000003,491.185,496.971,500.675,503.789,507.572,510.166,513.351" svgx:width="0.48,0.48,0.17,0.55,0.56,0.53,0.29,0.26,0.21,0.48,0.21,0.54,0.55,0.58,0.5,0.17,0.55,0.77,0.52,0.44,0.21,0.53,0.36,0.17,0.55,0.45,0.55,0.54,0.21,0.53,0.21,0.53,0.54,0.21,0.44,0.45,0.21,0.21,0.44,0.55,0.29,0.48,0.21,0.48,0.45,0.45,0.53,0.3,0.55,0.54,0.21,0.44,0.44,0.45,0.53,0.55,0.54,0.45,0.29,0.29,0.21,0.48,0.29,0.55,0.21,0.53,0.55,0.81,0.52,0.44,0.53,0.36,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">35. Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal</text>
   <text y="131.583" x="319.749,323.603,325.676,329.46,331.612,335.024,338.138,340.29,341.772,345.555,349.338,350.613,352.63,356.192,357.674,361.458,364.571,368.355,369.837,375.912,377.802,381.364,382.846,386.629,390.484,394.267,397.381,400.08099999999996,402.122,406.276,409.39,411.542,414.917,416.862,419.03700000000003,421.058,425.432,428.845,432.82000000000005,434.777,438.04,441.745,445.6,447.082,448.35699999999997,450.424,453.837,457.25,460.663,464.076,465.258,468.671,472.084,475.497,478.91,480.092,483.505,486.918" svgx:width="0.54,0.29,0.53,0.3,0.48,0.44,0.3,0.21,0.53,0.53,0.17,0.55,0.5,0.21,0.53,0.44,0.53,0.21,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.44,0.36,0.55,0.58,0.44,0.3,0.45,0.55,0.29,0.55,0.61,0.48,0.53,0.55,0.46,0.52,0.54,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">protection. Biochim Biophys Acta - Gen Subj. 1850;2015:236</text>
   <text y="131.583" x="490.338" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="131.583" x="493.91,497.322,500.735" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">52.</text>
   <text y="140.88" x="304.725,308.138,311.551,312.82599999999996,319.749,323.311,327.094,329.688,333.288,335.225,340.711,344.716,345.991,348.038,351.6,355.013,357.607,361.461,362.943,365.017,368.201,370.353,374.137,376.21,379.51,381.486,383.638,385.711,388.896,392.009,394.259,396.282,402.068,405.773,408.886,410.368,414.343,416.295,420.149,423.562,427.345,430.758,433.45799999999997,435.513,438.698,442.482,446.53200000000004,448.496,454.281,457.986,461.1,462.582,466.557,468.508,472.363,473.845,476.958,480.072,483.855,487.71,489.783,493.566,495.718,499.131,500.613,504.396,507.096,509.156,510.638,514.6129999999999,516.526,520.309,523.722,526.907,528.389,530.54" svgx:width="0.48,0.48,0.17,0.55,0.5,0.53,0.36,0.48,0.55,0.77,0.56,0.17,0.55,0.5,0.48,0.36,0.54,0.21,0.29,0.45,0.3,0.53,0.29,0.44,0.55,0.3,0.29,0.45,0.44,0.3,0.55,0.81,0.52,0.44,0.21,0.53,0.55,0.54,0.48,0.53,0.48,0.36,0.55,0.45,0.53,0.54,0.55,0.81,0.52,0.44,0.21,0.53,0.55,0.54,0.21,0.44,0.44,0.53,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.36,0.55,0.21,0.53,0.55,0.53,0.48,0.45,0.21,0.3,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">36. Rose MC. Respiratory tract mucin genes and mucin glycoproteins in health</text>
   <text y="149.838" x="319.749,322.933,326.717,330.767,332.675,336.529,338.011,340.605,344.017,347.202,349.796,353.209,354.484,356.542,360.104,363.887,367.001,369.594,371.076,374.86,376.435,378.538,382.101,385.514,388.698,389.97299999999996,391.974,395.387,398.8,402.213,405.626,406.809,410.221,413.634,414.817,418.23,421.643" svgx:width="0.45,0.53,0.54,0.55,0.54,0.21,0.36,0.48,0.45,0.36,0.48,0.17,0.55,0.5,0.53,0.44,0.36,0.21,0.53,0.21,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and disease. Physiol Rev. 2006;86:245</text>
   <text y="149.838" x="425.084" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="149.838" x="428.656,432.069,435.482" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">78.</text>
   <text y="159.135" x="304.725,308.138,311.551,312.82599999999996,319.749,324.123,327.828,333.90299999999996,335.735,338.179,341.742,343.017,345.09,349.543,353.51800000000003,355.464,357.908,360.352,361.62699999999995,363.684,367.247,369.32,372.505,374.657,376.907,378.934,384.72,387.983,389.258,391.293,395.746,397.228,400.342,403.306,406.006,408.074,410.518,416.303,417.578,419.639,424.092,425.574,427.056,428.631,430.637,434.791,438.054,439.32899999999995,441.408,444.971,446.453,450.236,453.421,454.903,456.478,458.53,461.714,464.978,466.253,468.281,471.843,475.626,479.481,482.894,484.967,487.119,490.902,494.877,496.854,501.008,506.494,507.769,509.836,513.099,518.215,521.4,522.882,524.364,528.147" svgx:width="0.48,0.48,0.17,0.55,0.61,0.52,0.81,0.55,0.34,0.5,0.17,0.55,0.63,0.53,0.55,0.34,0.34,0.17,0.55,0.5,0.29,0.45,0.3,0.3,0.55,0.81,0.46,0.17,0.55,0.63,0.21,0.44,0.42,0.36,0.55,0.34,0.81,0.17,0.55,0.63,0.21,0.21,0.21,0.55,0.58,0.46,0.17,0.55,0.5,0.21,0.53,0.45,0.21,0.21,0.55,0.45,0.46,0.17,0.55,0.5,0.53,0.54,0.48,0.29,0.3,0.53,0.53,0.55,0.58,0.77,0.17,0.55,0.46,0.72,0.45,0.21,0.21,0.53,0.72" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">37. Gum JR, Ho JJ, Pratt WS, Hicks JW, Hill AS, Vinall LE, Roberton AM, Swallow</text>
   <text y="168.093" x="319.749,324.344,329.83,331.10499999999996,333.128,336.612,338.094,344.169,346.054,349.616,352.879,354.154,356.202,361.688,366.141,370.145,373.745,375.704,379.487,383.192,388.978,392.163,396.13800000000003,398.098,399.58,403.363,405.515,408.927,411.521,413.673,415.155,418.938,422.123,423.698,425.707,431.492,435.197,438.311,439.793,443.576,444.851,446.91,451.063,454.847,458.032,459.514,462.627,465.221,466.703,469.40299999999996,471.457,475.24,477.19,479.224,483.078,486.491,490.275,493.875,495.835,498.428,500.58,502.653,506.358,509.472,511.624,515.329,517.402,520.815,522.09,524.181,526.332,530.116" svgx:width="0.64,0.77,0.17,0.55,0.49,0.21,0.81,0.55,0.5,0.46,0.17,0.55,0.77,0.63,0.56,0.48,0.55,0.53,0.52,0.81,0.45,0.53,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.81,0.52,0.44,0.21,0.53,0.17,0.55,0.58,0.53,0.45,0.21,0.44,0.36,0.21,0.36,0.55,0.53,0.26,0.55,0.54,0.48,0.53,0.48,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.17,0.55,0.3,0.53,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">DM, Kim YS. MUC3 human intestinal mucin. Analysis of gene structure, the</text>
   <text y="177.107" x="319.749,322.862,326.047,328.12,331.975,335.758,338.801,341.914,343.489,345.543,347.695,351.108,353.181,358.967,360.449,364.232,367.937,370.531,371.806,373.833,377.018,380.801,384.851,386.815,390.19,392.145,395.928,399.711,402.896,406.309,407.884,409.946,413.651,417.505,420.099,422.25,424.324,427.736,430.921,436.996,438.858,440.932,444.345,448.199,451.612,453.764,455.246,457.398,458.879,462.064,465.66400000000004,467.601,469.674,473.087,476.942,478.424,482.207,485.99,487.265,489.371,491.921,493.963,497.525,499.007,502.79,504.365,506.378,510.382,514.165,517.578,523.363" svgx:width="0.44,0.45,0.29,0.54,0.53,0.43,0.44,0.21,0.55,0.3,0.48,0.29,0.81,0.21,0.53,0.52,0.36,0.17,0.55,0.45,0.53,0.54,0.55,0.45,0.55,0.53,0.53,0.45,0.48,0.21,0.55,0.52,0.54,0.36,0.3,0.29,0.48,0.45,0.81,0.55,0.29,0.48,0.54,0.48,0.3,0.21,0.3,0.21,0.45,0.48,0.55,0.29,0.48,0.54,0.21,0.53,0.53,0.17,0.55,0.34,0.55,0.5,0.21,0.53,0.21,0.55,0.56,0.53,0.48,0.81,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">carboxyl terminus, and a novel upstream repetitive region. J Biol Chem.</text>
   <text y="186.121" x="319.749,323.161,326.574,329.987,333.4,334.583,337.995,341.408,344.821,346.004,349.417,352.83,356.242,359.655" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">1997;272:26678</text>
   <text y="186.121" x="363.062" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="186.121" x="366.634,370.047,373.46" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">86.</text>
   <text y="195.362" x="304.725,308.138,311.551,312.82599999999996,319.749,323.012,326.425,328.498,332.281,335.466,339.249,343.104,346.517,349.517,351.439,354.703,355.97799999999995,358.073,360.517,363.701,367.485,371.268,372.75,376.725,378.652,382.214,383.489,385.568,389.13,392.913,396.768,398.25,401.663,403.838,405.864,408.308,412.903,414.178,416.238,419.801,421.283,423.434,425.586,428.999,431.17400000000004,433.189,437.713,438.988,441.069,446.555,449.74,453.524,455.006,458.418,460.593,462.612,466.175,467.45,469.528,473.532,476.717,478.791,480.864,482.346,485.759,487.832,491.432,493.395,496.658,497.933,499.972,503.976,507.759,513.544,517.399,520.584,522.657,525.842,527.994,529.476,532.661" svgx:width="0.48,0.48,0.17,0.55,0.46,0.48,0.29,0.53,0.45,0.53,0.54,0.48,0.4,0.55,0.46,0.17,0.55,0.34,0.45,0.53,0.53,0.21,0.53,0.55,0.5,0.17,0.55,0.5,0.53,0.54,0.21,0.48,0.29,0.55,0.34,0.64,0.17,0.55,0.5,0.21,0.3,0.3,0.48,0.29,0.55,0.63,0.17,0.55,0.77,0.45,0.53,0.21,0.48,0.29,0.55,0.5,0.17,0.55,0.56,0.45,0.29,0.29,0.21,0.48,0.29,0.48,0.55,0.46,0.17,0.55,0.56,0.53,0.81,0.54,0.45,0.29,0.45,0.3,0.21,0.45,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">38. Fernandez S, Jannin V, Rodier JD, Ritter N, Mahler B, Carrière F. Comparative</text>
   <text y="204.376" x="319.749,322.342,324.494,328.199,332.053,335.353,337.267,341.05,345.02500000000003,347.018,350.872,352.354,356.209,359.622,362.215,364.367,365.849,369.034,372.634,374.57,376.052,377.534,381.388,384.573,387.167,390.767,392.768,395.953,399.067,401.218,402.7,405.885,407.367,409.519,411.001,414.414,417.114,419.13,422.913,426.88800000000003,428.824,430.976,434.759,438.35900000000004,440.333,442.926,446.339,447.821,449.771,451.785,455.197,460.983,464.688,466.17,468.763,470.245,472.098,475.211,476.693,480.477,484.527,486.536,489.949,492.991,496.105,497.587,501.442,502.924,506.336,510.12" svgx:width="0.36,0.3,0.52,0.54,0.44,0.55,0.53,0.53,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.45,0.48,0.55,0.21,0.21,0.54,0.45,0.36,0.48,0.55,0.45,0.44,0.3,0.21,0.45,0.21,0.3,0.21,0.48,0.36,0.55,0.53,0.53,0.55,0.3,0.53,0.48,0.55,0.36,0.48,0.21,0.26,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.48,0.43,0.44,0.21,0.54,0.21,0.48,0.53,0.3" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">study on digestive lipase activities on the self emulsifying excipient</text>
   <text y="213.39" x="319.749,322.933,326.118,329.973,332.046,335.231,337.824,341.608,343.09,345.833,347.108,349.172,354.957,358.37,362.224,363.706,367.411,373.486,375.363,378.477,382.26,385.445,386.927,390.90200000000004,392.824,396.679,398.161,401.275,404.388,407.801,409.874,411.356,415.211,418.624,421.324,423.381,426.566,430.349,434.399,436.363,439.926,443.189,447.764,449.686,453.099,455.692,457.844,461.257,463.33,465.924,467.19899999999996,469.245,472.807,474.289,478.073,481.186,484.969,486.451,492.526,494.416,497.979,499.461,503.244,507.099,510.882,513.996,516.696,518.737,522.891,526.005,528.156,531.531,533.477" svgx:width="0.45,0.45,0.54,0.29,0.45,0.36,0.53,0.21,0.38,0.17,0.55,0.81,0.48,0.54,0.21,0.52,0.81,0.55,0.44,0.53,0.45,0.21,0.53,0.55,0.54,0.21,0.44,0.44,0.48,0.29,0.21,0.54,0.48,0.36,0.55,0.45,0.53,0.54,0.55,0.5,0.46,0.61,0.55,0.48,0.36,0.3,0.48,0.29,0.36,0.17,0.55,0.5,0.21,0.53,0.44,0.53,0.21,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.44,0.36,0.55,0.58,0.44,0.3,0.45,0.55,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Labrasol®, medium chain glycerides and PEG esters. Biochim Biophys Acta -</text>
   <text y="222.348" x="319.749,325.235,329.018,330.59299999999996,332.617,336.622,340.035,341.516,343.091,345.147,348.709,350.191,353.974,355.549,357.619,360.804,362.286,366.14,367.622,371.477,374.07,375.34499999999997,377.404,380.817,384.23,387.642,391.055,392.238,395.651,399.064,402.477,405.889,407.072,410.485,413.898" svgx:width="0.77,0.53,0.21,0.55,0.56,0.48,0.21,0.21,0.55,0.5,0.21,0.53,0.21,0.55,0.45,0.21,0.54,0.21,0.54,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Mol Cell Biol Lipids. 2007;1771:633</text>
   <text y="222.348" x="417.318" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="222.348" x="420.889,424.302,427.715" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">40.</text>
   <text y="231.646" x="304.725,308.138,311.551,312.82599999999996,319.749,323.311,326.496,329.46,332.645,334.127,337.502,339.42" svgx:width="0.48,0.48,0.17,0.55,0.5,0.45,0.42,0.45,0.21,0.45,0.55,0.63" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">39. Bakala N</text>
   <text y="231.646" x="343.957" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">’</text>
   <text y="231.646" x="345.147,349.522,353.305,359.091,362.466,364.422,366.866,370.87,372.145,374.23,378.384,384.169,387.354,389.427,392.802,394.752,398.016,399.291,401.329,405.924,407.998,409.48,413.334,414.909,416.976,420.46,421.73499999999996,423.778,426.222,429.407,433.19,436.974,438.456,442.43100000000004,444.414,447.977,449.25199999999995,451.274,455.278,458.463,460.537,462.61,464.092,467.505,469.578,473.178,475.141,478.404,479.679,481.717,486.171,489.954,493.808,497.221,499.295,501.888,504.04,507.225,511.008,514.863,516.345,520.128,524.178,526.163,528.315,532.098" svgx:width="0.61,0.53,0.81,0.45,0.55,0.34,0.56,0.17,0.55,0.58,0.81,0.45,0.29,0.45,0.55,0.46,0.17,0.55,0.64,0.29,0.21,0.54,0.21,0.55,0.49,0.17,0.55,0.34,0.45,0.53,0.53,0.21,0.53,0.55,0.5,0.17,0.55,0.56,0.45,0.29,0.29,0.21,0.48,0.29,0.48,0.55,0.46,0.17,0.55,0.63,0.53,0.54,0.48,0.29,0.36,0.3,0.45,0.53,0.54,0.21,0.53,0.54,0.55,0.3,0.53,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Goma JC, Amara S, Dridi K, Jannin V, Carrière F. Understanding the</text>
   <text y="240.66" x="319.749,321.23,322.712,326.567,328.049,331.904,333.977,337.831,339.313,343.168,346.581,349.174,351.326,352.808,356.591,360.56600000000003,362.494,366.349,368.422,372.206,375.319,378.732,381.326,383.919,387.332,390.032,392.088,393.57,397.545,399.515,401.666,405.45,409.05,410.967,415.341,416.916,419.017,421.169,423.242,426.427,429.54,431.79,433.813,437.668,441.081,442.933,446.717,448.79,452.39000000000004,454.336,458.19,461.603,464.197,465.679,469.533,473.317,474.799,478.582,482.632,484.61,486.092,487.574,491.428,492.91,496.765,498.838,502.693,505.877,508.471,511.884,515.934,517.888,521.742,523.816,527.521,531.375" svgx:width="0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.55,0.54,0.29,0.53,0.44,0.48,0.36,0.36,0.48,0.36,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.61,0.21,0.55,0.3,0.29,0.45,0.44,0.3,0.55,0.54,0.48,0.26,0.53,0.29,0.48,0.55,0.54,0.48,0.36,0.21,0.54,0.53,0.21,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.54,0.29,0.52,0.54,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">lipid-digestion processes in the GI tract before designing lipid-based drug-</text>
   <text y="249.618" x="319.749,323.603,327.016,328.498,329.98,333.165,336.578,338.651,341.951,343.899,346.493,349.606,352.2,354.351,357.764,363.55,366.143,367.41799999999995,369.467,372.73,376.513,379.926,382.101,384.15,388.745,392.158,393.64,395.122,398.307,399.582,401.668,405.081,408.494,411.906,415.319,416.502,419.915,421.098,424.51,427.923" svgx:width="0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.46,0.53,0.48,0.29,0.55,0.64,0.48,0.21,0.21,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">delivery systems. Ther Deliv. 2012;3:105</text>
   <text y="249.618" x="431.32" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="249.618" x="434.892,438.305,441.718" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">24.</text>
   <text y="258.915" x="304.725,308.138,311.551,312.82599999999996,319.749,323.311,326.496,329.46,332.645,334.127,337.311,339.385" svgx:width="0.48,0.48,0.17,0.55,0.5,0.45,0.42,0.45,0.21,0.45,0.29,0.63" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">40. Bakala-N</text>
   <text y="258.915" x="343.9" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">’</text>
   <text y="258.915" x="345.09,349.465,353.248,359.034,362.409,364.365,366.809,370.813,372.08799999999997,374.173,379.958,381.44,382.922,384.404,385.886,389.071,394.856,397.556,399.571,404.024,408.62,409.895,411.93,415.193,418.378,420.971,423.565,426.978,430.761,434.36100000000005,436.364,439.926,442.37,443.645,445.661,449.145,450.627,454.04,457.895,461.308,463.381,467.431,469.415,472.899,474.174,476.218,480.222,483.407,484.889,488.743,492.156,494.23,498.013,501.796,505.396,507.342,512.828,514.103,516.186,518.63,521.814,525.598,529.381,530.863" svgx:width="0.61,0.53,0.81,0.45,0.55,0.34,0.56,0.17,0.55,0.81,0.21,0.21,0.21,0.21,0.45,0.81,0.36,0.55,0.63,0.64,0.17,0.55,0.46,0.45,0.36,0.36,0.48,0.53,0.48,0.55,0.5,0.34,0.17,0.55,0.49,0.21,0.48,0.54,0.48,0.29,0.54,0.55,0.49,0.17,0.55,0.56,0.45,0.21,0.54,0.48,0.29,0.53,0.53,0.48,0.55,0.77,0.17,0.55,0.34,0.45,0.53,0.53,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Goma JC, Williams HD, Sassene PJ, Kleberg K, Calderone M, Jannin</text>
   <text y="267.872" x="319.749,323.311,324.58599999999996,326.608,328.09,331.945,335.728,339.512,340.994,344.96900000000005,346.904,351.058,352.33299999999997,354.388,357.95,361.135,363.208,365.36,369.143,372.556,374.038,375.613,377.688,381.842,383.11699999999996,385.171,390.658,393.842,395.916,399.029,402.813,405.998,409.703,413.753,415.728,420.324,421.599,423.665,426.109,429.814,431.296,434.896,436.818,440.081,441.356,443.394,446.807,449.057,451.104,454.289,455.771,457.046,459.097,462.361,466.144,471.26,474.444,476.518,480.568,482.568,484.719,488.503,492.103,494.019,497.432,500.026,502.178,505.362,509.217,510.699,512.181,514.774,518.558,524.343,527.756,531.539" svgx:width="0.5,0.17,0.55,0.21,0.54,0.53,0.53,0.21,0.53,0.55,0.58,0.17,0.55,0.5,0.45,0.29,0.3,0.53,0.48,0.21,0.21,0.55,0.58,0.17,0.55,0.77,0.45,0.29,0.44,0.53,0.45,0.52,0.54,0.55,0.64,0.17,0.55,0.34,0.52,0.21,0.48,0.55,0.46,0.17,0.55,0.48,0.3,0.55,0.45,0.21,0.17,0.55,0.46,0.53,0.72,0.45,0.29,0.54,0.55,0.3,0.53,0.48,0.55,0.48,0.36,0.3,0.45,0.54,0.21,0.21,0.36,0.53,0.81,0.48,0.53,0.3" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">V, Igonin A, Partheil A, Marchaud D, Jule E, et al. Toward the establishment</text>
   <text y="276.887" x="319.749,323.532,325.48199999999997,327.515,330.109,332.261,335.445,339.229,343.083,346.268,348.342,352.196,353.678,356.492,359.905,363.955,365.896,367.378,371.353,373.323,376.508,377.99,380.141,382.215,386.19,388.12,390.272,393.684,396.278,398.43,401.13,403.2,405.052,408.836,411.011,413.064,414.546,416.028,419.883,421.365,425.219,427.293,431.147,434.332,436.925,440.338,444.38800000000003,446.342,448.195,451.978,454.052,459.837,463.542,465.024,468.209,470.361,471.843,475.626,479.409,482.003,483.27799999999996,485.346,488.759,490.034,492.093,495.278,496.76,500.614,504.398,505.88,508.993,511.587,513.069,515.769,517.831,521.614" svgx:width="0.53,0.26,0.55,0.36,0.3,0.45,0.53,0.54,0.45,0.29,0.54,0.21,0.4,0.48,0.54,0.55,0.21,0.53,0.55,0.45,0.21,0.3,0.29,0.53,0.55,0.3,0.48,0.36,0.3,0.36,0.55,0.26,0.53,0.29,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.17,0.55,0.48,0.17,0.55,0.45,0.21,0.54,0.53,0.21,0.44,0.36,0.21,0.36,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of</text>
   <text y="285.901" x="319.749,321.822,325.235,329.089,331.163,334.575,337.169,340.582,344.365,346.517,349.702,351.853,353.335,356.52,360.12,362.097,363.949,367.733,369.806,375.591,379.296,380.778,383.963,386.115,387.597,391.38,395.164,397.864,399.91,403.765,407.065,408.981,412.835,416.02,418.614,420.766,422.839,424.321,427.62100000000004,429.617,431.099,432.581,436.435,439.62,442.214,445.626,446.90099999999995,448.949,452.511,456.295,459.479,461.553,467.628,469.471,473.034,476.447,479.04,480.315,482.397,485.81,489.223,492.636,496.049,497.232,500.644,504.057,505.24,508.653,512.066,515.478" svgx:width="0.29,0.48,0.54,0.29,0.48,0.36,0.48,0.53,0.3,0.45,0.3,0.21,0.45,0.48,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.54,0.44,0.55,0.54,0.45,0.36,0.3,0.29,0.21,0.44,0.55,0.21,0.21,0.54,0.45,0.36,0.48,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">representative formulations by gastric lipase. Pharm Res. 2015;32:1279</text>
   <text y="285.901" x="518.912" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="285.901" x="522.483,525.896,529.309" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">87.</text>
   <text y="295.141" x="304.725,308.138,311.551,312.82599999999996,319.749,323.753,326.722,328.795,330.69,332.172,335.452,337.526,341.12600000000003,342.652,345.915,347.19,348.832,350.314,355.975,359.717,362.902,365.84,368.09,369.808,373.591,375.541,377.235,380.977,384.162,386.589,388.741,390.614,394.398,395.716,399.5,401.499,404.787,407.381,409.379,410.74,414.523,417.543,419.118,420.888,422.249,423.731,427.408,431.191,432.51,435.624,438.066,439.427,442.127,443.849,447.632,451.607,453.203,456.986,458.872,461.934,463.509,465.279,466.64,468.122,471.855,473.216,477.071,478.999,482.741,485.926,488.353,491.766,495.81600000000003,497.367,499.219,502.809,504.883,510.52,514.225,515.509,518.694,520.668,522.15,525.77,529.553" svgx:width="0.48,0.48,0.17,0.55,0.56,0.45,0.29,0.29,0.21,0.48,0.29,0.48,0.55,0.46,0.17,0.55,0.21,0.81,0.54,0.45,0.44,0.3,0.55,0.53,0.26,0.55,0.54,0.45,0.36,0.3,0.29,0.53,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.21,0.21,0.54,0.53,0.21,0.44,0.36,0.21,0.36,0.55,0.53,0.53,0.55,0.53,0.29,0.45,0.21,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">41. Carrière F. Impact of gastrointestinal lipolysis on oral lipid-based formulations</text>
   <text y="304.155" x="319.749,322.81,326.593,330.64300000000003,332.221,335.963,337.445,341.066,344.25,347.245,350.43,351.78,353.141,356.326,360.001,361.483,362.779,364.261,366.237,369.53700000000003,371.226,375.009,376.959,378.596,380.078,381.374,385.228,388.857,392.599,396.383,397.701,399.062,400.544,403.844,405.412,409.266,411.194,414.899,418.564,421.158,422.433,424.12,427.683,428.939,432.722,435.686,439.469,440.788,446.457,447.939,451.162,452.43699999999995,454.224,457.512,460.925,464.145,467.558,468.567,471.98,475.257,478.545,479.728,482.967,486.379" svgx:width="0.45,0.53,0.54,0.55,0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.5,0.21,0.53,0.44,0.53,0.21,0.81,0.21,0.48,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">and bioavailability of lipophilic drugs. Biochimie. 2016;125:297</text>
   <text y="304.155" x="489.601" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="304.155" x="493.116,496.404,499.817,503.037" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">305.</text>
   <text y="313.396" x="304.725,308.138,311.551,312.82599999999996,319.749,323.233,326.835,329.649,330.917,334.7,336.019,339.432,342.582,344.126,349.612,350.887,352.573,356.577,359.603,361.676,363.572,364.932,368.345,370.261,373.86100000000005,375.534,378.797,380.072,381.713,385.276,388.856,390.93,392.938,396.226,398.401,400.138,404.142,406.431,410.884,412.159,413.801,416.986,418.279,422.134,423.439,427.293,429.993,431.659,433.141,437.11600000000004,438.689,440.841,444.415,448.01500000000004,449.687,452.281,454.223,458.007,463.634,466.819,469.756,473.731,475.369,477.54400000000004,479.281,480.763,486.367,490.109,491.591,492.943,496.057,499.066,501.218,502.524,506.308,509.894,512.594,514.317,516.169,519.759,521.934,523.671,525.823,529.454" svgx:width="0.48,0.48,0.17,0.55,0.49,0.53,0.4,0.21,0.53,0.21,0.48,0.42,0.55,0.77,0.17,0.55,0.56,0.45,0.29,0.29,0.21,0.48,0.29,0.48,0.55,0.46,0.17,0.55,0.5,0.53,0.29,0.3,0.48,0.29,0.55,0.56,0.34,0.63,0.17,0.55,0.45,0.21,0.54,0.21,0.54,0.36,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.36,0.3,0.53,0.81,0.45,0.44,0.53,0.55,0.29,0.55,0.21,0.81,0.54,0.21,0.21,0.44,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.26,0.53,0.29,0.55,0.3,0.53,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">42. Koziolek M, Carrière F, Porter CJH. Lipids in the stomach - implications for the</text>
   <text y="322.41" x="319.749,323.037,326.221,329.273,330.634,334.339,337.381,339.532,340.839,344.622,348.59700000000004,350.136,353.92,355.87,357.506,359.359,362.949,366.732,370.78200000000004,372.36,375.648,377.501,379.22,382.508,385.622,387.61,390.31,392.032,395.815,399.79,401.329,405.113,407.055,410.117,411.692,413.462,417.204,419.277,422.816,426.866,428.542,431.604,435.458,437.897,441.68,443.566,447.42,449.405,450.766,454.55,458.193,459.46799999999996,461.198,464.76,468.341,471.526,473.443,481.097,484.659,487.844,490.437,491.712,493.4,496.688,500.101,503.377,506.665,507.848,511.087,514.5,515.509,518.922,522.142" svgx:width="0.48,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.26,0.53,0.53,0.54,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.36,0.55,0.53,0.53,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">evaluation of food effects on oral drug absorption. PharmRes. 2018;35:55.</text>
   <text y="331.651" x="304.725,308.138,311.551,312.82599999999996,319.749,323.311,327.094,329.168,331.319,334.732,336.90700000000004,338.91,342.914,345.358,349.811,351.08599999999996,353.14,356.403,358.477,361.889,365.074,368.259,370.853,373.817,375.299,377.99899999999997,380.069,384.593,387.778,389.053,391.124,395.128,398.911,402.096,404.169,409.955,413.14,417.115,419.073,424.858,429.382,430.657,432.678,435.863,437.345,441.2,442.682,446.536,449.236,451.33,454.515,458.298,462.348,464.256,465.738,467.22,471.074,472.556,476.411,478.484,482.339,485.524,488.117,491.53,495.58,497.591,499.443,503.226,505.3,511.085,514.79,516.272,519.457,521.609,523.091,526.874,530.657,533.251" svgx:width="0.48,0.48,0.17,0.55,0.5,0.53,0.29,0.3,0.48,0.29,0.55,0.56,0.34,0.63,0.17,0.55,0.46,0.29,0.48,0.45,0.45,0.36,0.42,0.21,0.36,0.55,0.63,0.45,0.17,0.55,0.56,0.53,0.45,0.29,0.81,0.45,0.53,0.55,0.81,0.63,0.17,0.55,0.45,0.21,0.54,0.21,0.54,0.36,0.55,0.45,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">43. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations:</text>
   <text y="340.665" x="319.749,323.532,327.386,329.538,331.02,336.806,338.288,341.102,342.584,346.367,350.41700000000003,352.346,354.498,358.281,361.88100000000003,363.855,367.638,369.711,372.896,374.471,376.497,380.352,383.764,385.246,386.728,389.913,393.326,395.399,398.699,400.705,404.488,406.438,408.471,409.953,411.435,415.29,419.073,422.928,426.711,428.193,429.675,431.157,434.457,436.42,440.275,442.348,446.053,449.908,452.501,453.77599999999995,455.809,460.333,463.518,465.768,467.828,471.39,474.803,478.178,480.13,484.726,486.799,490.504,494.55400000000003,496.514,501.109,502.591,505.185,508.298,512.082,515.267,516.542,518.624,522.037,525.449,528.862,532.275,533.458,536.871" svgx:width="0.53,0.54,0.3,0.21,0.81,0.21,0.4,0.21,0.53,0.54,0.55,0.3,0.53,0.48,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.63,0.45,0.3,0.55,0.5,0.48,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.21,0.36,0.44,0.53,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:</text>
   <text y="349.679" x="319.749,323.161,326.574" svgx:width="0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">231</text>
   <text y="349.679" x="329.953" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="349.679" x="333.525,336.938,340.351" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">48.</text>
   <text y="358.92" x="304.725,308.138,311.551,312.82599999999996,319.749,324.273,325.755,328.868,332.652,334.134,337.319,341.102,343.80199999999996,345.826,350.201,351.476,353.536,357.54,359.614,362.799,366.504,369.097,371.249,374.662,376.735,382.221,385.406,389.189,392.303,393.785,397.198,399.448,401.498,404.761,406.036,408.074,411.337,414.522,416.595,418.077,421.861,425.644,427.796,429.947,431.522,433.585,437.148,438.423,440.501,444.064,446.137,449.921,452.514,455.108,458.292,460.366,464.416,466.353,470.948,472.22299999999996,474.29,475.772,481.557,485.412,487.485,491.269,494.453,497.866,503.652,507.065,510.848,513.098,515.165,518.948" svgx:width="0.48,0.48,0.17,0.55,0.63,0.21,0.44,0.53,0.21,0.45,0.53,0.36,0.55,0.61,0.17,0.55,0.56,0.29,0.45,0.52,0.36,0.3,0.48,0.29,0.77,0.45,0.53,0.44,0.21,0.48,0.3,0.55,0.46,0.17,0.55,0.46,0.45,0.29,0.21,0.53,0.53,0.3,0.3,0.21,0.55,0.5,0.17,0.55,0.5,0.29,0.53,0.36,0.36,0.45,0.29,0.54,0.55,0.64,0.17,0.55,0.21,0.81,0.54,0.29,0.53,0.45,0.48,0.81,0.48,0.53,0.3,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">44. Nicolaos G, Crauste-Manciet S, Farinotti R, Brossard D. Improvement of</text>
   <text y="367.934" x="319.749,322.862,326.275,328.127,331.982,335.765,339.62,343.403,346.446,347.928,353.713,357.31300000000005,359.263,363.117,365.19,368.974,372.016,375.429,377.581,379.063,380.638,382.676,386.46,388.533,391.718,393.293,395.375,398.56,402.415,405.008,408.791,410.865,414.719,416.871,418.353,422.136,426.11100000000005,428.029,429.511,433.48600000000005,435.456,437.53,440.714,442.866,445.566,447.589,451.443,454.743,456.716,459.901,463.87600000000003,465.844,469.627,471.109,472.591,474.665,476.147,479.93,482.003,487.119,490.304,492.455,495.868,498.043,500.086,502.679,506.384,510.239,516.024,517.506,520.62,522.693,526.476" svgx:width="0.44,0.48,0.26,0.54,0.53,0.54,0.53,0.43,0.21,0.81,0.48,0.55,0.54,0.29,0.53,0.43,0.48,0.3,0.21,0.21,0.55,0.53,0.29,0.45,0.21,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.21,0.53,0.55,0.29,0.45,0.3,0.36,0.55,0.54,0.44,0.55,0.45,0.53,0.55,0.53,0.21,0.21,0.29,0.21,0.53,0.29,0.72,0.45,0.3,0.48,0.29,0.55,0.36,0.52,0.54,0.81,0.21,0.44,0.29,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron</text>
   <text y="376.948" x="319.749,323.161,328.947,332.652,334.134,336.727,338.209,341.992,345.776,347.051,349.115,350.596,354.38,356.63,358.639,361.189,363.231,366.794,370.577,373.762,375.835,381.62,382.895,384.944,388.357,391.77,395.183,398.596,399.778,403.191,406.604,410.017,411.2,414.612,418.025" svgx:width="0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.17,0.55,0.21,0.53,0.3,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">emulsion. Int J Pharm. 2003;263:165</text>
   <text y="376.948" x="421.456" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="376.948" x="425.027,428.44,431.853" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">71.</text>
   <text y="386.189" x="304.725,308.138,311.551,312.82599999999996,319.749,323.012,326.197,328.348,332.132,335.837,337.91,341.693,344.393,346.394,350.989,355.364,356.63899999999995,358.695,362.258,365.671,367.744,371.599,375.011,378.795,381.388,383.54,386.725,390.508,392.08299999999997,394.185,397.747,399.022,401.044,406.531,410.236,411.718,413.2,416.612,418.686,420.837,423.837,425.818,429.972,431.24699999999996,433.302,438.788,442.571,444.645,448.499,452.282,456.066,457.548,461.331,465.186,466.668,469.781,472.966,474.541,476.614,480.397,484.252,486.845,490.258,492.332,495.516,498.701,500.853,502.335,506.118,509.902,512.602,514.654,518.437,522.412,524.348" svgx:width="0.48,0.48,0.17,0.55,0.46,0.45,0.3,0.53,0.52,0.29,0.53,0.36,0.55,0.64,0.61,0.17,0.55,0.5,0.48,0.29,0.54,0.48,0.53,0.36,0.3,0.45,0.53,0.21,0.55,0.5,0.17,0.55,0.77,0.52,0.21,0.21,0.48,0.29,0.3,0.4,0.55,0.58,0.17,0.55,0.77,0.53,0.29,0.54,0.53,0.53,0.21,0.53,0.54,0.21,0.44,0.45,0.21,0.55,0.53,0.54,0.36,0.48,0.29,0.45,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.53,0.53,0.55,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">45. Fatouros DG, Bergenstahl B, Mullertz A. Morphological observations on a</text>
   <text y="395.203" x="319.749,321.23,322.712,326.567,328.049,331.904,335.758,338.943,341.536,344.949,348.999,350.929,354.784,356.857,360.562,364.612,366.576,370.431,373.844,375.326,376.808,379.992,383.405,385.479,388.779,390.727,393.32,396.434,399.027,401.179,404.592,410.667,412.553,416.408,420.113,422.186,423.668,427.451,431.50100000000003,433.473,434.955,438.93,440.843,444.028,445.51,447.661,449.735,453.71000000000004,455.696,459.551,461.033,464.887,468.3,470.893,473.045,474.527,478.31,482.094,483.36899999999997,485.403,488.666,492.371,494.546,496.628,499.178,501.22,504.782,508.566,511.751,513.824,519.899,521.742,525.006,528.119,529.601" svgx:width="0.21,0.21,0.54,0.21,0.54,0.54,0.45,0.36,0.48,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.55,0.54,0.52,0.29,0.21,0.53,0.54,0.55,0.21,0.53,0.55,0.45,0.21,0.3,0.29,0.53,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.17,0.55,0.46,0.52,0.29,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">lipidbased drug delivery system during in vitro digestion. Eur J Pharm Sci.</text>
   <text y="404.217" x="319.749,323.161,326.574,329.987,333.4,336.585,337.767,341.18,344.593,345.776,349.189" svgx:width="0.48,0.48,0.48,0.48,0.45,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2007a;31:85</text>
   <text y="404.217" x="352.574" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="404.217" x="356.145,359.558,362.971" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">94.</text>
   <text y="413.458" x="304.725,308.138,311.551,312.82599999999996,319.749,323.012,326.197,328.348,332.132,335.837,337.91,341.693,344.393,346.394,350.989,355.364,356.63899999999995,358.695,363.291,366.704,370.117,374.09200000000004,376.043,380.418,383.98,385.255,387.325,391.479,393.552,395.034,398.447,400.598,404.57300000000004,406.543,409.728,411.003,413.063,416.625,420.038,422.111,425.966,429.379,433.162,435.756,437.907,441.092,444.875,446.45,448.495,452.057,453.332,455.355,459.879,461.361,464.774,466.256,468.849,472.262,476.237,478.202,481.465,484.728,486.003,488.066,491.628,495.041,498.896,502.309,504.382,506.975,510.388,514.3629999999999,516.298,518.742,522.005" svgx:width="0.48,0.48,0.17,0.55,0.46,0.45,0.3,0.53,0.52,0.29,0.53,0.36,0.55,0.64,0.61,0.17,0.55,0.64,0.48,0.48,0.53,0.55,0.61,0.5,0.17,0.55,0.58,0.29,0.21,0.48,0.3,0.53,0.55,0.45,0.17,0.55,0.5,0.48,0.29,0.54,0.48,0.53,0.36,0.3,0.45,0.53,0.21,0.55,0.5,0.17,0.55,0.63,0.21,0.48,0.21,0.36,0.48,0.53,0.55,0.46,0.46,0.17,0.55,0.5,0.48,0.54,0.48,0.29,0.36,0.48,0.53,0.55,0.34,0.46,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">46. Fatouros DG, Deen GR, Arleth L, Bergenstahl B, Nielsen FS, Pedersen JS,</text>
   <text y="422.472" x="319.749,325.235,328.94,330.422,331.904,335.316,337.39,339.541,342.541,344.466,348.62,349.895,351.949,355.213,357.364,359.438,363.143,366.256,368.408,372.113,374.186,377.371,378.94599999999997,381.033,384.887,388.3,391.485,394.898,396.38,400.163,404.018,409.803,413.216,416.999,419.249,421.283,425.067,427.017,429.107,431.701,435.114,436.596,438.546,440.559,444.342,447.527,451.311,455.286,457.226,460.639,466.425,470.13,471.612,474.205,475.687,477.54,480.653,482.135,485.918,489.968,491.922,495.776,497.85,501.555,505.605,507.569,511.423,514.836,516.318,517.8,520.985,524.398,526.471" svgx:width="0.77,0.52,0.21,0.21,0.48,0.29,0.3,0.4,0.55,0.58,0.17,0.55,0.46,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.45,0.21,0.55,0.54,0.48,0.45,0.48,0.21,0.53,0.54,0.81,0.48,0.53,0.3,0.55,0.53,0.26,0.55,0.36,0.48,0.21,0.26,0.55,0.53,0.45,0.53,0.53,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Mullertz A. Structural development of self nano emulsifying drug delivery</text>
   <text y="431.486" x="319.749,322.342,325.456,328.049,330.201,333.614,339.399,342.099,344.126,345.978,349.241,353.766,357.029,361.625,366.22,369.483,371.433,373.492,377.346,381.051,383.125,384.607,388.39,392.44,394.411,395.893,399.868,401.781,404.966,406.448,408.6,410.673,414.648,416.634,418.116,419.598,423.453,424.935,428.985,430.921,434.775,436.257,440.112,443.525,446.118,448.27,449.752,453.535,457.51000000000005,459.494,465.279,469.062,472.846,474.328,476.479,480.263,482.336,485.749,489.79900000000004,491.751,495.605,498.90500000000003,500.822,503.415,509.201,512.385,513.867,515.349,517.423,520.608,524.391,528.245,529.727" svgx:width="0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.55,0.26,0.46,0.63,0.46,0.64,0.64,0.46,0.26,0.55,0.54,0.52,0.29,0.21,0.53,0.54,0.55,0.21,0.53,0.55,0.45,0.21,0.3,0.29,0.53,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.55,0.81,0.53,0.53,0.21,0.3,0.53,0.29,0.48,0.54,0.55,0.54,0.44,0.55,0.36,0.81,0.45,0.21,0.21,0.29,0.45,0.53,0.54,0.21,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">systems (SNEDDS) during in vitro lipid digestion monitored by small-angle</text>
   <text y="440.443" x="319.749,323.603,325.676,327.75,330.935,334.235,336.189,338.783,341.896,345.081,347.233,349.385,352.797,354.871,356.353,360.136,363.991,365.26599999999996,367.313,370.875,374.659,377.844,379.917,385.99199999999996,387.836,391.398,394.811,397.404,398.679,400.762,404.174,407.587,411.0,414.413,418.268,419.45,422.863,426.276,427.459,430.872,434.284,437.697" svgx:width="0.54,0.29,0.29,0.45,0.44,0.55,0.36,0.44,0.45,0.3,0.3,0.48,0.29,0.21,0.53,0.54,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.54,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">X-ray scattering. Pharm Res. 2007b;24:1844</text>
   <text y="440.443" x="441.128" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="440.443" x="444.7,448.113,451.526" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">53.</text>
   <text y="449.741" x="304.725,308.138,311.551,312.82599999999996,319.749,324.123,327.907,329.389,333.243,334.725,338.508,342.558,344.466,349.952,351.227,353.31,359.096,362.879,366.662,369.256,371.408,374.821,376.99600000000004,379.048,382.312,384.755,386.03,388.062,391.325,395.109,398.709,400.648,402.13,405.913,407.765,409.247,412.952,416.365,420.148,423.262,426.862,428.823,432.606,434.556,436.647,440.06,445.845,449.55,451.032,453.626,455.108,458.891,462.86600000000004,464.823,467.417,469.568,471.642,475.347,478.46,480.612,484.317,486.39,489.99,491.922,495.107,498.89,502.94,504.904,507.498,509.649,512.834,516.689,518.171,519.653,521.135,523.287,526.587,528.545,532.328" svgx:width="0.48,0.48,0.17,0.55,0.61,0.53,0.21,0.54,0.21,0.53,0.54,0.55,0.77,0.17,0.55,0.81,0.53,0.53,0.36,0.3,0.48,0.29,0.55,0.46,0.34,0.17,0.55,0.46,0.53,0.48,0.55,0.21,0.53,0.26,0.21,0.52,0.48,0.53,0.44,0.48,0.55,0.53,0.26,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.55,0.45,0.53,0.54,0.55,0.36,0.3,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">47. Golding M, Wooster TJ. The influence of emulsion structure and stability on</text>
   <text y="458.698" x="319.749,321.23,322.712,326.567,328.049,332.099,334.035,337.889,339.371,343.226,346.639,349.232,351.384,352.866,356.649,360.432,361.707,363.741,367.745,371.45,373.524,375.699,377.744,382.489,386.344,387.825,391.8,393.788,397.792,401.575,403.057,404.539,408.322,409.804,413.854,415.784,417.266,421.05,423.201,426.614,428.687,430.54,433.725,436.838,440.43800000000005,442.429,445.693,448.806,450.288,451.563,453.598,457.01,460.423,463.836,467.249,468.432,471.845,475.257,476.44,479.853" svgx:width="0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.21,0.54,0.48,0.36,0.3,0.21,0.53,0.53,0.17,0.55,0.56,0.52,0.29,0.29,0.55,0.67,0.54,0.21,0.53,0.55,0.56,0.53,0.21,0.21,0.53,0.21,0.54,0.55,0.21,0.53,0.3,0.48,0.29,0.26,0.45,0.44,0.48,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">lipid digestion. Curr Opin Colloid Interface Sci. 2010;15:90</text>
   <text y="458.698" x="483.308" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="458.698" x="486.822,490.235,493.648,497.061" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">101.</text>
   <text y="467.995" x="304.724,308.137,311.55,312.825,319.748,323.752,326.937,328.512,330.519,334.303,335.578,337.663,343.448,346.633,350.416,354.466,356.428,359.99,361.265,363.287,367.071,370.854,374.75399999999996,376.724,379.908,382.352,383.62699999999995,385.681,388.866,390.348,394.248,396.169,399.952,404.697,405.972,408.018,412.542,415.727,419.51,423.293,426.407,429.592,431.665,433.739,435.22,438.633,440.707,443.3,444.575,446.681,450.056,452.01,455.865,459.278,463.061,466.474,468.547,471.732,473.307,475.367,477.961,480.112,482.186,485.371,487.522,490.935,494.79,498.09000000000003,500.028,501.88,505.664" svgx:width="0.48,0.48,0.17,0.55,0.56,0.45,0.21,0.55,0.53,0.17,0.55,0.81,0.45,0.53,0.54,0.55,0.5,0.17,0.55,0.53,0.53,0.52,0.55,0.45,0.34,0.17,0.55,0.45,0.21,0.52,0.55,0.53,0.67,0.17,0.55,0.63,0.45,0.53,0.53,0.44,0.45,0.29,0.29,0.21,0.48,0.29,0.36,0.17,0.55,0.45,0.55,0.54,0.48,0.53,0.48,0.29,0.45,0.21,0.55,0.36,0.3,0.29,0.45,0.3,0.48,0.54,0.44,0.55,0.26,0.53,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">48. Cai Z, Wang Y, Zhu LJ, Liu ZQ. Nanocarriers: a general strategy for</text>
   <text y="476.952" x="319.748,323.161,326.944,330.727,333.912,337.695,340.809,344.222,350.007,353.42,357.203,359.453,361.473,365.256,367.20599999999996,369.24,373.023,375.096,378.281,379.856,381.938,385.793,387.275,391.058,394.243,397.428,400.613,402.095,403.577,406.761,410.616,412.098,413.58,415.062,417.214,420.514,422.473,426.256,428.20599999999996,430.239,434.094,437.877,441.661,443.734,445.216,448.516,450.478,453.663,457.518,460.111,463.895,465.968,469.823,473.235,477.285,479.278,483.061,485.236,487.271,491.126,493.199,496.612,498.685,501.279,504.393,506.986,509.138,512.551,518.336,519.818,522.932,526.116,527.598,529.08" svgx:width="0.48,0.53,0.53,0.45,0.53,0.44,0.48,0.81,0.48,0.53,0.3,0.55,0.53,0.26,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.54,0.53,0.53,0.29,0.21,0.44,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.48,0.54,0.55,0.53,0.29,0.55,0.54,0.29,0.48,0.29,0.36,0.44,0.36,0.3,0.48,0.81,0.21,0.44,0.45,0.21,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">enhancement of oral bioavailability of poorly absorbed or pre-systemically</text>
   <text y="485.967" x="319.748,325.533,328.946,331.098,334.283,338.137,341.921,343.402,344.884,347.699,351.112,355.16200000000003,357.108,360.963,363.036,366.741,370.595,373.189,374.464,376.496,380.5,384.205,386.279,388.454,390.556,395.151,397.225,400.93,404.98,406.883,412.369,415.782,417.934,421.119,424.973,426.248,428.313,431.726,435.139,438.551,441.964,443.147,446.56,449.973,451.155,454.568,457.981" svgx:width="0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.4,0.48,0.54,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.56,0.52,0.29,0.29,0.55,0.64,0.29,0.52,0.54,0.55,0.77,0.48,0.3,0.45,0.54,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">metabolized drugs. Curr Drug Metab. 2010;11:197</text>
   <text y="485.967" x="461.424" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="485.967" x="464.995,468.408,471.821,475.234" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">207.</text>
   <text y="495.264" x="304.724,308.137,311.55,312.825,319.748,323.752,327.535,330.72,334.69500000000005,336.642,339.827,345.313,348.577,349.852,351.893,355.077,358.861,363.976,367.389,370.089,372.132,375.395,376.66999999999996,378.708,383.161,384.643,386.716,389.31,391.56,393.618,397.181,401.634,402.909,404.957,408.22,412.003,415.603,417.542,421.696,425.258,429.263,431.96299999999997,433.983,437.766,439.716,441.807,445.661,447.735,451.44,455.49,457.397,459.548,461.622,464.807,468.59,471.183,475.038,478.821,480.895,483.145,485.232,486.714,490.689,492.659,494.141,497.925,500.076,503.489,506.083,508.234,509.716,513.5,517.1,519.021,522.206,525.989" svgx:width="0.48,0.48,0.17,0.55,0.56,0.53,0.45,0.53,0.55,0.45,0.77,0.46,0.17,0.55,0.45,0.53,0.72,0.48,0.36,0.55,0.46,0.17,0.55,0.63,0.21,0.29,0.36,0.3,0.55,0.5,0.63,0.17,0.55,0.46,0.53,0.48,0.55,0.58,0.5,0.56,0.36,0.55,0.53,0.26,0.55,0.54,0.29,0.52,0.54,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.55,0.21,0.53,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.48,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">49. Chan LMS, Lowes S, Hirst BH. The ABCs of drug transport in intestine and</text>
   <text y="504.222" x="319.748,321.23,322.712,325.897,329.309,331.383,332.65799999999996,334.714,338.127,339.98,341.832,343.314,347.019,350.244,352.175,356.03,358.103,361.887,364.038,367.451,368.933,372.716,375.416,377.46,378.942,380.424,386.21,387.692,389.843,391.325,395.109,399.159,401.101,404.955,407.029,410.733,414.783,416.748,419.932,423.787,426.381,430.164,432.237,436.092,438.243,439.725,443.509,447.48400000000004,449.459,452.644,456.427,460.47700000000003,462.441,466.296,467.778,471.561,474.746,477.931,481.116,482.597,484.079,487.264,491.119,492.601,494.083,495.565,497.716,500.83,502.10499999999996,504.166,507.429,511.134,513.309,515.391,517.9409999999999,519.983,523.546,527.329,530.514,532.587" svgx:width="0.21,0.21,0.45,0.48,0.29,0.17,0.55,0.48,0.26,0.26,0.21,0.52,0.43,0.55,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.36,0.55,0.21,0.21,0.81,0.21,0.3,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.17,0.55,0.46,0.52,0.29,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm</text>
   <text y="513.236" x="319.748,323.011,326.125,327.607,328.882,330.916,334.329,337.742,341.155,344.567,345.75,349.163,352.576,353.759,357.171" svgx:width="0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Sci. 2004;21:25</text>
   <text y="513.236" x="360.567" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="513.236" x="364.139,367.552,370.964" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">51.</text>
   <text y="522.477" x="304.724,308.137,311.55,312.825,319.748,323.31,327.094,329.167,331.319,334.731,336.906,338.91,342.914,345.358,349.811,351.08599999999996,353.139,356.702,360.485,364.19,366.342,370.125,374.1,376.043,380.047,385.833,387.108,389.196,393.2,396.905,398.387,402.17,405.77000000000004,407.734,410.178,413.441,414.71599999999995,416.748,420.752,424.535,427.72,429.793,435.579,438.764,442.73900000000003,444.697,450.482,455.006,456.28099999999995,458.359,461.622,465.406,469.189,472.374,476.157,479.271,480.753,484.536,488.586,490.503,491.985,495.769,497.92,501.333,503.927,506.078,507.56,511.344,514.529,516.104,518.169,522.023,524.097,527.802" svgx:width="0.48,0.48,0.17,0.55,0.5,0.53,0.29,0.3,0.48,0.29,0.55,0.56,0.34,0.63,0.17,0.55,0.5,0.53,0.52,0.3,0.53,0.53,0.55,0.56,0.81,0.17,0.55,0.56,0.52,0.21,0.53,0.48,0.55,0.34,0.46,0.17,0.55,0.56,0.53,0.45,0.29,0.81,0.45,0.53,0.55,0.81,0.63,0.17,0.55,0.46,0.53,0.53,0.45,0.53,0.44,0.21,0.53,0.54,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.54,0.29,0.52,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">50. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug</text>
   <text y="531.491" x="319.748,322.341,326.125,327.607,331.311,335.166,336.648,338.13,339.612,342.205,345.39,347.542,349.024,352.807,356.78200000000004,358.752,362.457,365.05,366.532,370.315,374.365,376.326,377.808,379.29,383.144,384.626,388.481,390.554,394.409,397.594,400.187,403.6,407.65000000000003,409.604,413.459,416.872,418.354,419.836,423.02,426.433,428.507,431.807,433.755,436.348,439.462,442.055,444.207,447.62,453.405,455.999,457.274,459.323,463.476,467.331,470.706,472.702,477.297,479.371,483.076,487.12600000000003,489.085,493.681,497.094,498.576,500.058,503.433,505.356,508.918,512.331,515.516,516.7909999999999,518.848,522.261,525.674,529.087,532.5" svgx:width="0.36,0.53,0.21,0.52,0.54,0.21,0.21,0.21,0.36,0.45,0.3,0.21,0.53,0.53,0.55,0.52,0.36,0.21,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;</text>
   <text y="540.505" x="319.748,323.161,326.573,327.756,331.169,334.582" svgx:width="0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">60:673</text>
   <text y="540.505" x="338.003" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="540.505" x="341.518,344.931,348.344" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">91.</text>
   <text y="549.746" x="304.724,308.137,311.55,312.825,319.748,324.201,325.683,329.466,331.618,334.432,337.845,341.82000000000005,343.729,346.992,348.267,350.362,353.925,357.337,359.411,362.824,364.897,368.272,370.204,374.579,375.854,377.914,382.367,385.552,389.257,393.112,395.263,397.857,400.009,403.421,404.903,408.87800000000004,410.852,414.115,415.39,417.428,422.914,426.619,428.101,429.583,432.996,435.171,437.213,441.217,442.49199999999996,444.526,447.711,450.896,452.748,454.601,456.083,459.496,463.201,465.37600000000003,467.43,470.693,471.96799999999996,474.063,477.626,481.039,483.112,486.895,489.859,493.643,497.497,499.57,502.834,505.947,509.731,513.514,517.219,519.292,522.406,526.381,528.317,532.471" svgx:width="0.48,0.48,0.17,0.55,0.63,0.21,0.53,0.3,0.4,0.48,0.53,0.55,0.46,0.17,0.55,0.5,0.48,0.29,0.48,0.29,0.45,0.55,0.61,0.17,0.55,0.63,0.45,0.52,0.54,0.3,0.36,0.3,0.48,0.21,0.53,0.55,0.46,0.17,0.55,0.77,0.52,0.21,0.21,0.48,0.29,0.55,0.56,0.17,0.55,0.45,0.45,0.26,0.26,0.21,0.48,0.52,0.29,0.55,0.46,0.17,0.55,0.5,0.48,0.29,0.53,0.42,0.53,0.54,0.29,0.46,0.44,0.53,0.53,0.52,0.29,0.44,0.53,0.55,0.58,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">51. Hintzen F, Perera G, Hauptstein S, Müller C, Laffleur F, Bernkop-Schnürch A.</text>
   <text y="558.765" x="319.748,321.152,324.977,326.891,329.855,331.259,334.223" svgx:width="0.2,0.51,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">In vivo</text>
   <text y="558.765" x="339.931,343.344,346.528,349.713,351.195,354.9,358.085,360.237,361.719,365.502,369.47700000000003,371.451,375.235,377.185,379.218,382.403,386.37800000000004,388.346,392.129,394.203,397.387,398.962,401.045,403.638,407.051,408.533,410.385,412.459,418.244,419.726,422.84,424.913,428.696,432.109,437.895,441.6,443.081,445.675,447.157,449.009,452.123,453.605,457.388,461.438,463.405,467.26,469.333,473.038,477.088,479.052,482.907,486.32,487.802,489.284,492.468,495.881,497.955,501.255,503.203,505.796,508.91,511.503,513.655,517.068" svgx:width="0.48,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.45,0.53,0.55,0.53,0.29,0.45,0.21,0.55,0.36,0.48,0.21,0.26,0.29,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">evaluation of an oral self-microemulsifying drug delivery system</text>
   <text y="567.779" x="319.748,321.6,324.864,330.35,333.613,338.209,342.804,346.067,348.017,350.078,351.93,355.714,357.889,359.885,361.367,364.78,368.485,372.34,374.413,378.196,380.27,383.683,385.165,386.647,390.43,391.705,393.787,395.269,399.052,401.302,403.368,405.918,407.96,411.522,415.306,418.491,420.564,426.349,427.62399999999997,429.673,433.086,436.499,439.912,443.324,444.507,447.92,451.333,454.746,455.928,459.341" svgx:width="0.26,0.46,0.77,0.46,0.64,0.64,0.46,0.26,0.55,0.26,0.53,0.29,0.55,0.21,0.48,0.52,0.54,0.29,0.53,0.29,0.48,0.21,0.21,0.53,0.17,0.55,0.21,0.53,0.3,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">(SMEDDS) for leuprorelin. Int J Pharm. 2014;472:20</text>
   <text y="567.779" x="462.728" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="567.779" x="466.299,469.712" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">6.</text>
   <text y="577.02" x="304.724,308.137,311.55,312.825,319.748,324.344,327.528,331.312,334.497,338.47200000000004,340.384,344.538,345.813,347.867,352.32,356.104,357.956,359.809,365.594,368.779,372.754,374.739,378.893,380.16799999999995,382.222,385.485,389.269,392.869,394.807,398.22,400.073,401.925,405.338,408.452,410.702,412.722,416.506,418.45599999999996,420.546,424.401,425.883,427.735,429.588,433.001,435.074,438.487,442.27,444.52,446.568,448.05,449.532,453.386,454.868,458.918,460.854,464.709,467.893,470.487,473.9,477.95,479.902,481.755,485.538,487.612,493.397,497.102,498.584,501.769,503.921,505.403,509.186,512.969,515.6690000000001,517.716,521.499,525.474,527.41,529.562,533.345" svgx:width="0.48,0.48,0.17,0.55,0.64,0.45,0.53,0.45,0.53,0.55,0.58,0.17,0.55,0.63,0.53,0.26,0.26,0.81,0.45,0.53,0.55,0.58,0.17,0.55,0.46,0.53,0.48,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.54,0.21,0.26,0.26,0.48,0.29,0.48,0.53,0.3,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.45,0.36,0.48,0.54,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.53,0.53,0.55,0.3,0.53,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">52. Dahan A, Hoffman A. The effect of different lipid based formulations on the</text>
   <text y="586.034" x="319.748,323.531,325.605,328.789,330.364,332.39,335.575,339.43,342.023,345.807,347.88,351.735,353.886,355.368,359.152,363.127,365.102,368.885,370.835,372.868,374.35,375.832,379.687,383.47,387.325,391.108,392.59,394.072,395.554,398.854,400.817,404.672,406.745,410.45,414.305,416.898,418.173,420.263,422.414,426.198,429.798,431.714,434.899,438.754,440.236,441.718,443.2,445.352,448.652,450.65,454.433,456.383,458.417,459.898,463.87300000000005,465.843,469.028,470.51,472.662,474.735,478.71000000000004,480.64,482.122,483.604,487.459,491.242,492.724,495.838,498.431,499.913,502.613,504.678,507.863,511.646" svgx:width="0.53,0.29,0.45,0.21,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.3,0.53,0.48,0.55,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.21,0.53,0.55,0.45,0.21,0.3,0.29,0.53,0.55,0.21,0.21,0.54,0.53,0.21,0.44,0.36,0.21,0.36,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">oral absorption of lipophilic drugs: the ability of in vitro lipolysis and</text>
   <text y="595.048" x="319.748,322.862,326.645,330.428,333.022,336.435,339.548,343.253,345.405,346.887,350.072" svgx:width="0.44,0.53,0.53,0.36,0.48,0.44,0.52,0.3,0.21,0.45,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">consecutive</text>
   <text y="595.048" x="355.635,358.599,361.599,363.628,366.592,367.996,370.96" svgx:width="0.42,0.4,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;">ex vivo</text>
   <text y="595.048" x="376.668,378.15,381.933,384.085,387.498,390.091,392.243,393.725,397.508,400.693,402.268,404.333,408.188,411.601,413.674,419.46,422.872,426.057,429.912,431.394,432.876,434.358,436.509,439.809,441.75,445.604,448.789,450.941,454.316,456.32,458.471,462.446,464.37,468.225,470.298,473.711,477.565,479.047,482.161,484.411,486.48,487.962,491.937,493.85,497.035,498.517,501.702" svgx:width="0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.54,0.48,0.29,0.81,0.48,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.54,0.45,0.3,0.45,0.55,0.3,0.53,0.55,0.54,0.29,0.48,0.54,0.21,0.44,0.3,0.55,0.21,0.53,0.55,0.45,0.21,0.45,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">intestinal permeability data to predict in vivo</text>
   <text y="604.005" x="319.748,323.603,325.085,328.868,332.053,335.238,338.422,339.904,341.386,344.571,348.426,349.908,351.39,352.872,355.023,358.32300000000004,360.282,361.764,365.73900000000003,367.709,369.783,372.967,375.119,377.713,378.988,381.032,384.295,388.0,390.175,392.2,394.75,396.792,400.355,404.138,407.323,409.396,415.471,417.372,420.934,422.416,426.2,430.054,433.838,437.022,439.096,444.881,446.15599999999995,448.212,451.625,455.038,458.451,461.863,463.046,466.459,469.872,471.055,474.467" svgx:width="0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.21,0.53,0.55,0.29,0.45,0.3,0.36,0.17,0.55,0.46,0.52,0.29,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">bioavailability in rats. Eur J Pharm Biopharm. 2007;67:96</text>
   <text y="604.005" x="477.865" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="604.005" x="481.437,484.85,488.263,491.675" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">105.</text>
   <text y="613.303" x="304.724,308.137,311.55,312.825,319.748,324.272,328.056,330.129,333.984,336.577,339.541,343.324,347.374,349.284,352.847,356.331,357.606,359.659,363.221,367.005,370.189,374.16400000000004,376.157,380.161,383.424,384.69899999999996,386.758,391.282,394.987,397.139,399.29,400.772,404.556,408.606,410.511,415.107,418.37,419.645,421.737,425.0,427.593,431.56800000000004,433.529,437.091,438.366,440.388,444.542,448.517,450.479,453.892,456.935,460.119,465.905,467.387,471.17,474.355,476.507,477.989,481.772,485.747,487.669,491.453,493.40299999999996,495.493,497.645,501.428,505.028,506.945,508.797,511.982,515.096,517.248,521.031,523.104" svgx:width="0.48,0.48,0.17,0.55,0.63,0.53,0.29,0.54,0.36,0.42,0.53,0.54,0.55,0.5,0.49,0.17,0.55,0.5,0.53,0.45,0.53,0.55,0.56,0.46,0.17,0.55,0.63,0.52,0.3,0.3,0.21,0.53,0.54,0.55,0.64,0.46,0.17,0.55,0.46,0.36,0.53,0.55,0.5,0.17,0.55,0.58,0.53,0.55,0.48,0.43,0.45,0.81,0.21,0.53,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.3,0.53,0.48,0.55,0.26,0.45,0.44,0.3,0.53,0.29,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">53. Nordskog BK, Phan CT, Nutting DF, Tso P. An examination of the factors</text>
   <text y="622.26" x="319.748,322.933,324.785,326.638,330.051,333.164,335.316,336.798,340.581,344.63100000000003,346.563,348.045,351.829,353.98,357.393,359.987,362.138,363.62,367.404,370.589,372.164,374.229,375.711,378.824,384.61,388.464,392.248,395.432,397.584,399.066,402.366,404.332,406.484,408.557,411.742,415.525,418.119,421.973,425.757,427.83,430.08,432.111,435.895,437.84499999999997,439.935,443.789,445.271,448.684,450.836,454.021,456.094,459.394,461.307,462.789,464.271,468.126,469.608,473.462,476.056,477.33099999999996,479.449,483.602,487.457,490.832,492.771,497.367,499.44,503.145,507.195,509.155,513.751,517.164,518.646,520.128,523.503,525.426,528.988,532.401,535.586" svgx:width="0.45,0.26,0.26,0.48,0.44,0.3,0.21,0.53,0.54,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.21,0.44,0.81,0.54,0.53,0.45,0.3,0.21,0.44,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.55,0.53,0.26,0.55,0.54,0.21,0.48,0.3,0.45,0.29,0.44,0.55,0.21,0.21,0.54,0.21,0.54,0.36,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">affecting intestinal lymphatic transport of dietary lipids. Adv Drug Deliv Rev.</text>
   <text y="631.274" x="319.748,323.161,326.574,329.987,333.399,334.582,337.995,341.408,343.26,346.673,348.746,352.159,354.012,355.194,358.607" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.48,0.29,0.48,0.26,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">2001;50(1-2):21</text>
   <text y="631.274" x="361.984" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="631.274" x="365.556,368.969,372.382" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">44.</text>
   <text y="640.572" x="304.724,308.137,311.55,312.825,319.748,323.531,326.716,329.68,333.093,335.166,336.648,338.722,344.208,345.69,347.172,350.357,354.14,355.715,357.788,361.35,362.625,364.648,368.21,371.395,372.877,374.359,377.173,380.358,384.213,387.625,391.6,393.561,398.014,399.289,401.327,402.809,406.593,408.744,412.157,414.751,416.902,418.384,422.168,425.353,426.928,428.993,431.144,433.218,436.403,440.186,442.779,446.634,450.417,452.491,454.642,458.055,460.129,462.722,463.99699999999996,466.069,469.482,473.266,477.049,480.234,484.017,487.131,490.543,494.593,496.57,499.755,503.609,506.203,509.986,512.059,515.914,518.066,519.548,523.331" svgx:width="0.48,0.48,0.17,0.55,0.53,0.45,0.42,0.48,0.29,0.21,0.29,0.77,0.21,0.21,0.45,0.53,0.21,0.55,0.5,0.17,0.55,0.5,0.45,0.21,0.21,0.4,0.45,0.54,0.48,0.53,0.55,0.63,0.17,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.48,0.29,0.36,0.17,0.55,0.48,0.53,0.53,0.45,0.53,0.44,0.48,0.54,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">54. Zakeri-Milani P, Valizadeh H. Intestinal transporters: enhanced absorption</text>
   <text y="649.529" x="319.748,321.9,325.683,327.756,331.54,335.245,339.099,343.074,345.033,348.595,352.45,353.932,357.045,360.159,363.942,367.797,369.87,373.654,375.805,379.218,380.7,384.483,386.658,388.686,390.759,394.172,395.654,398.839,400.99,404.403,408.45300000000003,410.399,414.253,416.327,420.032,424.082,426.046,427.528,431.311,433.463,436.876,438.949,442.134,445.247,447.399,448.881,452.665,456.448,459.041,460.316,462.385,465.648,468.691,472.545,475.958,478.031,480.281,482.34,487.086,490.94,492.422,496.39700000000005,498.327,502.923,504.996,508.701,512.751,514.711,520.197,523.61,525.762,528.947" svgx:width="0.3,0.53,0.29,0.53,0.52,0.54,0.53,0.55,0.5,0.54,0.21,0.44,0.44,0.53,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.29,0.55,0.29,0.48,0.21,0.45,0.3,0.48,0.54,0.55,0.54,0.29,0.52,0.54,0.55,0.21,0.53,0.3,0.48,0.29,0.45,0.44,0.3,0.21,0.53,0.53,0.36,0.17,0.55,0.46,0.43,0.54,0.48,0.29,0.3,0.55,0.67,0.54,0.21,0.53,0.55,0.64,0.29,0.52,0.54,0.55,0.77,0.48,0.3,0.45,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">through Pglycoprotein- related drug interactions. Expert Opin Drug Metab</text>
   <text y="658.543" x="319.748,323.011,326.795,329.837,331.319,334.432,338.216,339.698,340.97299999999996,342.992,346.404,349.817,353.23,356.643,357.826,361.238,364.651,365.834,369.247,372.66" svgx:width="0.46,0.53,0.43,0.21,0.44,0.53,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Toxicol. 2014;10:859</text>
   <text y="658.543" x="376.101" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="658.543" x="379.673,383.086,386.498" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">71.</text>
   <text y="667.784" x="304.724,308.137,311.55,312.825,319.748,325.533,328.876,332.108,335.963,339.478,341.653,344.466,348.151,350.595,351.87,354.785,358.13,361.418,363.005,366.974,370.829,374.117,376.328,377.90299999999996,380.751,384.039,385.31399999999996,388.178,391.863,395.276,399.233,402.646,404.896,407.793,411.082,414.937,416.212,419.076,423.328,426.559,428.77,430.357,433.645,437.245,439.995,442.66,446.175,449.406,451.561,455.076,457.287,458.874,462.729,466.704,469.476,472.764,476.619,480.66900000000004,483.422,486.937,490.792,493.06,496.473,498.729,502.585,505.76,508.991,511.259,512.741,516.0409999999999,518.856,522.825,524.979,528.777" svgx:width="0.48,0.48,0.17,0.55,0.81,0.45,0.44,0.53,0.48,0.29,0.55,0.5,0.34,0.17,0.55,0.46,0.45,0.21,0.54,0.53,0.45,0.3,0.21,0.55,0.45,0.17,0.55,0.5,0.48,0.53,0.48,0.3,0.55,0.45,0.53,0.17,0.55,0.58,0.44,0.3,0.21,0.45,0.48,0.55,0.36,0.48,0.44,0.29,0.48,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.48,0.53,0.3,0.48,0.29,0.53,0.44,0.44,0.3,0.21,0.44,0.55,0.54,0.29,0.52,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">55. Wacher VJ, Salphati L, Benet LZ. Active secretion and enterocytic drug</text>
   <text y="676.798" x="319.748,325.533,329.102,331.357,334.541,338.556,342.412,343.996,345.581,348.277,354.352,357.008,360.976,364.264,366.44,368.616,370.2,373.715,375.891,378.591,381.447,383.658,387.63300000000004,390.405,394.259,396.527,400.326,404.37600000000003,407.128,410.313,414.328,416.993,420.879,423.055,427.012,429.223,430.807,434.693,438.579,439.854,442.661,446.917,450.875,454.25,456.998,461.703,463.879,467.687,471.737,474.489,479.195,482.607,484.24,485.825,489.2,491.948,495.577,499.092,502.379,503.654,506.518,510.033,513.446,517.006,520.521,521.806,525.219,528.78" svgx:width="0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.36,0.81,0.55,0.54,0.45,0.29,0.29,0.21,0.48,0.29,0.36,0.55,0.3,0.53,0.55,0.54,0.29,0.52,0.54,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">metabolism barriers to drug absorption. Adv Drug Deliv Rev. 2001;46:</text>
   <text y="685.812" x="319.748,323.161" svgx:width="0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">89</text>
   <text y="685.812" x="326.721" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="685.812" x="330.406,333.819,337.379,340.894" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">102.</text>
   <text y="695.053" x="304.724,308.137,311.55,312.825,319.748,325.533,328.718,330.87,333.834,335.316,339.099,341.799,343.842,347.405,350.967,352.24199999999996,354.274,357.537,361.32,364.92,366.859,370.714,373.899,375.972,378.045,379.527,382.94,385.115,387.155,389.007,392.712,396.495,399.609,401.761,403.243,407.026,411.00100000000003,413.006,416.789,418.739,420.773,424.777,428.339,431.902,435.315,439.468,443.06800000000004,444.98,448.165,451.948,455.998,457.963,461.525,463.598,467.453,468.935,472.049,475.162,478.945,482.8,484.873,488.657,490.808,494.221,495.703,499.678,501.672,503.154,507.129,509.042,511.193,514.977,518.577,520.551,523.144,528.93,532.114,533.596" svgx:width="0.48,0.48,0.17,0.55,0.81,0.45,0.3,0.42,0.21,0.53,0.36,0.55,0.5,0.5,0.17,0.55,0.46,0.53,0.48,0.55,0.54,0.45,0.29,0.29,0.21,0.48,0.29,0.55,0.26,0.52,0.53,0.44,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.56,0.5,0.5,0.48,0.58,0.48,0.55,0.45,0.53,0.54,0.55,0.5,0.29,0.54,0.21,0.44,0.44,0.53,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.36,0.81,0.45,0.21,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">56. Watkins PB. The barrier function of CYP3A4 and P-glycoprotein in the small</text>
   <text y="704.067" x="319.748,323.603,327.386,332.502,335.914,337.396,338.671,340.724,344.878,348.732,352.107,354.047,358.642,360.715,364.42,368.47,370.43,375.026,378.439,379.921,381.403,384.778,386.758,390.32,393.733,396.918,398.193,400.194,403.607,407.02,410.432,413.845,415.028,418.441,421.854,423.036,426.449,429.862" svgx:width="0.54,0.53,0.72,0.48,0.21,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">bowel. Adv Drug Deliv Rev. 1997;27:161</text>
   <text y="704.067" x="433.304" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="704.067" x="436.876,440.288,443.701" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">70.</text>
   <text y="713.307" x="304.724,308.137,311.55,312.825,319.748,323.093,326.891,329.783,333.581,336.643,338.21799999999996,341.064,345.6,346.875,349.739,353.084,356.882,360.851,362.438,365.613,368.901,374.797,378.172,380.92,384.548,385.823,388.687,392.315,396.227,397.709,401.309,404.164,408.019,409.969,412.781,418.677,422.192,424.403,427.691,431.66,435.515,437.102,438.69,441.99,444.756,448.169,452.126,455.017,458.249,464.034,467.603,470.303,473.159,476.447,480.303,484.353,487.106,490.62,492.548,494.475,496.062,499.861" svgx:width="0.48,0.48,0.17,0.55,0.46,0.52,0.4,0.52,0.42,0.21,0.55,0.63,0.17,0.55,0.46,0.52,0.54,0.21,0.44,0.45,0.81,0.45,0.55,0.5,0.17,0.55,0.5,0.53,0.21,0.48,0.55,0.53,0.26,0.55,0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.44,0.55,0.48,0.53,0.4,0.44,0.81,0.48,0.36,0.55,0.45,0.53,0.54,0.55,0.48,0.26,0.26,0.21,0.52,0.43" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">57. Suzuki H, Sugiyama Y. Role of metabolic enzymes and efflux</text>
   <text y="722.322" x="319.748,321.969,324.111,327.399,331.311,333.974,337.942,341.795,343.937,346.205,349.618,351.874,354.574,357.373,358.961,362.93600000000004,365.707,367.928,371.84,375.44,378.189,381.374,385.389,388.11,391.962,394.105,398.073,400.284,401.872,405.727,409.702,412.474,416.329,418.279,421.147,425.002,427.27,431.068,434.923,437.623,440.536,442.457,444.668,448.521,454.596,457.251,459.472,463.384,466.98400000000004,469.733,472.398,478.294,481.582,483.064,484.639,487.535,489.122,493.034,495.255,498.77,501.432,503.7,505.287,509.143,512.657,513.932,516.739,520.141,523.939,526.1139999999999,528.928" svgx:width="0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.48,0.29,0.36,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.54,0.29,0.52,0.54,0.36,0.55,0.26,0.29,0.53,0.81,0.55,0.3,0.53,0.48,0.55,0.36,0.81,0.45,0.21,0.21,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.48,0.17,0.55,0.46,0.52,0.29,0.55,0.34" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">transporters in the absorption of drugs from the small intestine. Eur J</text>
   <text y="731.336" x="319.748,323.404,327.28,330.559,332.725,338.8,341.456,344.858,348.032,349.62,350.895,353.759,357.172,360.732,364.238,367.744,368.992,372.498,376.004,377.252" svgx:width="0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">Pharm Sci. 2000;12:3</text>
   <text y="731.336" x="380.75" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;">–</text>
   <text y="731.336" x="384.435,387.848,391.408" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;">12.</text>
   <text y="39.005" x="56.693,61.021,64.853,67.429,71.261,77.925,80.501,84.501,88.996,93.492" svgx:width="0.54,0.48,0.32,0.48,0.83,0.32,0.5,0.56,0.56,0.47" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;">Katamreddy</text>
   <text y="39.005" x="99.552,103.128,105.608,107.999,112.159,113.903,115.58300000000001,117.978,121.474,123.218,127.378,129.122,133.282,136.162,138.557,140.301,144.541,146.948,151.948,155.524,159.684,161.428,163.924,168.16400000000002,170.532,174.692,178.94,183.1,185.499,190.659,192.403,195.315,198.891,203.051,205.963" svgx:width="0.45,0.31,0.55,0.52,0.22,0.21,0.55,0.44,0.22,0.52,0.22,0.52,0.36,0.55,0.22,0.53,0.55,0.63,0.45,0.52,0.22,0.31,0.53,0.55,0.52,0.53,0.52,0.55,0.64,0.22,0.36,0.45,0.52,0.36,0.45" style="fill:rgb(19,20,19);font-family:BgxxryAdvTT7329fd89.I;font-size:8.0px;stroke:none;">et al. Lipids in Health and Disease</text>
   <text y="39.005" x="211.861,213.557,215.829,219.932,224.036,228.14,232.244,234.516,236.212,240.316,244.42,246.076,250.18,254.284,258.388" svgx:width="0.21,0.28,0.51,0.51,0.51,0.51,0.28,0.21,0.51,0.51,0.21,0.51,0.51,0.51,0.21" style="fill:rgb(19,20,19);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;"> (2018) 17:112 </text>
   <text y="39.005" x="500.143,504.391,508.222,512.638,516.638,519.022,523.1020000000001,525.485,529.813,532.133,534.499" svgx:width="0.53,0.48,0.55,0.5,0.55,0.51,0.55,0.54,0.29,0.55,0.51" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;">Page 7 of 8</text>
  </g>
 </g>
</svg>
